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Abstract 
Asymmetric synthesis and catalysis is one of the leading research areas in chemistry society, 
for its versatility and efficiency in obtaining chiral molecules that found the vast majority in 
natural active compounds and synthetic drugs. Developing asymmetric catalytic methodology is 
at the frontier in both industrial and academic research laboratories. Enantioselective 
organocatalysis has emerged as a powerful synthetic tool that is complementary to metal-
catalyzed transformations. The development of chiral phosphoric acid and metal phosphate as 
catalysts has been a breakthrough in recent years. Chiral phosphoric acids have been shown to be 
powerful catalysts in many organic transformations. Moreover, chiral metal phosphates, which 
formed by simply replacing the proton in phosphoric acid with metals, have introduced new 
catalytic activations and broaden the scope of phosphoric acids. This thesis details new highly 
enantioselective chiral phosphoric acid-catalyzed Pinacol rearrangement and robust alkaline 
phosphates catalytic system, which utilizes novel carbonyl activation. 
The Pinacol rearrangement has long been known to be difficult to control in terms of 
regioselectivity and stereoselectivity. The initial studies found that indolyl-diol compounds can 
be treated with chiral phosphoric acids to afford the Pinacol rearrangement with high regio- and 
enantioselectivity. Over 16 chiral phosphoric acids were screened, and it was found an H8-
BINOL-phosphoric acid variant with 1-naphthyl groups at 3 and 3’ position was the excellent 
catalyst. This asymmetric transformation is tolerant toward variety of substituents both on the 
indole ring and migrating groups. 
 ix 
During the study, it was found that different ways to generate the catalyst had critical effect 
on this catalytic transformation. Only those phosphoric acids washed with HCl after column 
chromatography afforded the rearrangement products with high enantioselectivity. And those 
without treating with HCl were found contaminated by alkaline metals. These “contamination” 
catalysts were also found active with carbonyl activations.  
A highly enantioselective catalytic hetero-Diels-Alder reaction of α-keto esters has been 
developed with chiral alkaline metal phosphates. A calcium 1-naphthyl-BINOL phosphate was 
found to be the optimum catalyst. A large range of α-keto esters as well as isatins can be applied 
in this alkaline phosphates catalytic system with high efficiency and selectivity. The structure of 
the catalyst is detailed for the first time by X-ray crystal structure analysis. A proposed 
Transition state model is provided based on the catalyst crystal structure and Raman 
spectroscopy analysis.  
This methodology was further developed with an asymmetric Mukaiyama-Michael addition 
of β,γ-unsaturated α-keto ester. The best catalyst was found to be a magnesium chiral phosphate. 
And the transformation was found capable of tolerating a wide variety of β,γ-unsaturated α-keto 
esters.
 1 
 
 
 
 
 
Chapter 1 Organocatalytic Enantioselective Pinacol Rearrangement 
1.1 Asymmetric catalysis 
Organic chemistry community has been intrigued by the chirality of organic compounds ever 
since Jean-Baptiste Biot observed it in 1815. Chiral compounds often exhibit a large variety of 
biological activities because life contains enantiomeric molecules like amino acids and DNAs. 
And different enantiomers could show completely different biological effects towards life, 
regardless they are nearly identical in appearance.  
Thalidomide and ibuprofen are representatives which one enantiomer have beneficial effect 
while the opposite enantiomer shows no or even harmful activity (Figure 1.1). Study shows the R 
isomer of thalidomide can be used against nausea and to alleviate morning sickness in pregnant 
women; however its S isomer is responsible for birth defects. In the case of ibuprofen, only the S 
isomer was found to be active for relieving pain and helping with fever. The (R)-ibuprofen 
exhibits none of the beneficial activity as S isomer. 
 
Figure 1.1 Different enantiomers 
N
O
O
NH
O
O N
O
O
NH
O
O
(R)-thalidomide (S)-thalidomide
O
OH
(R)-ibuprofen
O
OH
(S)-ibuprofen
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Due to the significant difference in biological activities of the enantiomers, developing 
efficient routes to obtain enantiomeric pure compounds has been of great importance and 
become a research frontier in both academic and industrial labs. Up to date, widely applied 
methods for acquiring enantiomeric pure compounds molecules are engaging the chiral pool, 
chiral auxiliaries, chiral resolution and asymmetric catalysis. The asymmetric catalysis, which 
employs catalytic amount of chiral reagent to produce only one enantiomer and not two in the 
synthetic steps, can significantly shorten the synthetic route and avoid generating waste. By 
improving the synthetic efficiency and reducing the total cost, enantioselective catalysis has the 
advantage over other methods, and become the major research forefront nowadays. 
1.2 Organocatalysis 
The major discoveries of asymmetric catalysis are focused on developing chiral metal 
complexes as enantioselective catalysts. Metals often act as a Lewis acidic center, combined with 
expensive chiral ligands, to deliver chirality to the reaction product. More importantly, metals 
can be utilized as redox center to generate metal-carbon bonds, which can be further applied to 
carbon-carbon bond formation. However, the development of those methodologies inevitably 
suffers their drawbacks. The expensiveness of the transition metals involved and their sensitivity 
to air and moisture inhibit the application of metal catalysts in industrial process. The hardness of 
separating the trace amount of metal catalyst from precious products with susceptible biological 
activities makes the application more suspectable. To overcome those disadvantages, organic 
chemists developed organocatalysis as new catalytic methodologies that require no use of metals. 
Asymmetric organocatalysis, in which small chiral organic molecules used to catalyze 
enantioselective transformations, has become a fast growing research area since last one and a 
half decades. 
 3 
Organocatalysis could date back to 1912, when Fiske and Bredig reported the addition of 
cyanide to benzaldehyde assisted by quinine and quindine.1 The transformation afforded the 
optical active products, although the enantiomeric excess was only less than 10%. In 1970s, an 
intramolecular aldol reaction known as the Hajos-Parrish-Eder-Sauer-Wiechert process (Scheme 
1.1) was introduced as the first use of proline in a catalytic asymmetric aldol reaction.2 
 
Scheme 1.1 Hajos-Parrish-Eder-Sauer-Wiechert process 
The last 15 years has witnessed the boom in the development of asymmetric organocatalysis. 
The organocatalysis not only has become the complementary to metal-catalyzed transformations, 
but also introduces new activations of organic functional groups, which bring new ways to 
construct complex chiral molecules. During this period of time, several different types of 
organocatalysts have been presented to the community. On a mechanistic basis, the asymmetric 
organocatalysis can be divided into two subgroups, which are “covalent organocatalysis” and 
“noncovalent organocatalysis”.  
Enamine catalysis and Iminium catalysis are the typical examples for covalent 
organocatalysis, in which a covalent intermediate is formed between the catalyst and the 
substrate in the catalytic cycle. The enamine catalysis (Figure 1.2) proceeds through an enamine 
intermediate that is formed from chiral primary or secondary amines as catalysts and one 
carbonyl compound. The electron-rich enamine intermediate acted as a nucleophile attacking 
double bond or other electrophiles to afford the final product. 
O
O
H3CH3C
O O
OH3C
HO
N
H OH
O
DMF
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Figure 1.2 Catalytic cycle of enamine catalysis 
The origin report of asymmetric enamine catalysis was by Parrish and co-workers in 1974.2 
Although many mechanistic studies and computational work had been done to understand the 
catalytic process, no major breakthrough was inhibited for the rest of twenty years. In 2000, 
based on mechanistic study of biological aldolase enzymes in the same lab, List and co-workers 
reported an direct intermolecular aldol reaction between aldehydes and ketones catalyzed by a 
small chiral organic molecule proline (Scheme 1.2).3 The transformation applied proline with 
acetone to form enamine intermediate and reacted with aldehydes to provide the aldol products 
with from 60% to 96% ee. The amine-catalyzed reaction was conceptually novel and comparable 
to the best results of those organometallic catalysts of intermolecular aldol reaction. 
 
Scheme 1.2 Proline-catalyzed intermolecular Aldol reaction 
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The initial work by List and co-workers has leaded to the discovery of new enamine catalytic 
systems. The enamine catalytic enantioselective methodologies have been shown to be optimal 
for many α-functionalization of carbonyl compounds.4 
Instead of using chiral amine to generate enamine as nucleophile, the chiral amine can also 
be applied as electrophile activating catalyst by iminium formation, which is iminium catalysis 
(Figure 1.3). In this case, amine catalyst and the carbonyl compound condense to afford iminium 
ion. Without isomerizing to corresponding enamine, the iminium was realized to significantly 
lower the LUMO energy of the electrophile. Moreover, the chiral information from the catalytic 
amine is close to the electrophile when the iminium intermediate is formed. Therefore, high level 
of enantioselectivity can be delivered via iminium organocatalysis. 
 
Figure 1.3 Catalytic cycle of iminium catalysis 
Several iminium ion-mediated transformations were reported in the past one hundred years.5 
The real breakthrough in asymmetric iminium catalysis was the realization of imidazolidinone as 
catalyst introduced by MacMillan, just one month after List’s initial work.6 The enantioselective 
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Diels-Alder reaction that occurred between α,β-unsaturated aldehydes and variety of dienes was 
shown to be catalyzed by chiral amine with excellent yield and enantioselectivity (Scheme 1.3).  
 
Scheme 1.3 Imidazolidinone-catalyzed enantioselective Diels-Alder reaction 
The LUMO-lowering concept by iminium catalysis then largely spread into many other 
enantioselective transformations, including Michael-type additions, conjugated transfer 
hydrogenations, oxygenations as well as other important organic reactions. 
In contrast to the covalent organocatalysis, which forms convent bond between catalyst and 
substrate to deliver chirality in the transition state, noncovalent organocatalysis relies solely on 
weak but sufficient noncovalent interactions such as hydrogen bonding or coulombic attraction 
of ion pairs. The successful application of noncovalent organocatalysis in variety of 
enantioselective transformations makes it the brilliant component of the organocatalysis concept. 
Similar to metal-based Lewis acid catalysis, hydrogen bonding to the substrates such as 
carbonyls or imines would lower the LUMO of the electrophiles, which facilitates the 
nucleophilic attack. And the chirality can be delivered with the activation of electrophiles. In 
1981, the enantioselective Michael addition of thiols to α,β-unsaturated ketones using cinchona 
alkaloids as hydrogen bonding catalysts was reported by Wynberg and co-workers.7 In 1998, 
Jacobsen and Sigman reported a novel chiral thiourea catalyst to promote enantioselective 
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+
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Strecker reaction (Scheme 1.4) with excellent yield and up to 91% enantioselectivity.8 This 
thiourea hydrogen bonding catalyst was the outcome of the systematic screening of a library of 
chiral aluminum catalysts, and it was found the two hydrogen bonds formed between thiourea 
and imine were sufficient to activate both aromatic and aliphatic imines. 
 
Scheme 1.4 Thiourea-catalyzed enantioselective Strecker reaction 
Chiral thiourea catalysis has made a huge impact on the development of organocatalysis, for 
it has proven the capability of weak hydrogen bond interaction to activate the electrophiles and 
discriminate enantiotopic faces, without involving Lewis acid and base interaction, which is 
believed to be a stronger interaction. Up to now, thiourea catalysts have been used for Pictet-
Spengler reaction, Morita-Bayliss-Hillmen reaction, and cyanosilylation of ketones, as well as 
many others. 
Not only the N-H bonds from thiourea is capable to form hydrogen bonds with electrophiles, 
chiral diols can also been employed as Brønsted acids to provide hydrogen bonds to the 
substrates. In 2003, Rawal and co-workers reported the excellent enantioselective hetero-Diels-
Alder reaction using TADDOL (tetraaryl-1,3-dioxolan-4,5-dimethanol) itself as chiral hydrogen 
bonding catalyst (Scheme 1.5).9 It is well known that TADDOL was developed as chiral ligands 
for metal complexes and chiral resolution reagents. This transformation tolerated a variety of 
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aldehydes and resulted in cycloaddition products with excellent enantioselectivities. This 
achievement has inspirited many works on the activation of carbonyls and imines, and influenced 
the studies of chiral Brønsted acid catalysts. 
 
Scheme 1.5 TADDOL-catalyzed enantioselective hetero-Diels-Alder reaction 
1.3 Enantioselective phosphoric acid catalysis 
The noncovalent catalysts such as thiourea and chiral diols mentioned before are considered 
to be Brønsted acids, which provide interaction with substrates via hydrogen bonding. However 
the acidities of those are rather weak, with pKa values from 20 to 28 in DMSO.10 Thus, they are 
considered to be weak or neutral Brønsted acids. While the studies of those catalysts in variety of 
enantioselective transformations are fruitful, there are still many organic transformations demand 
the development of new catalysts that possess stronger acidic functionalities, which can 
protonate the substrates. In 2004, Akiyama11 and Terada12 independently reported chiral 
phosphoric acids as strong Brønsted acid catalysts in enantioselective Mannich reactions 
(Scheme 1.6). 
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Scheme 1.6 Akiyama and Terada’s chiral phosphoric acid-catalyzed Mannich reaction 
The unique phosphoric acids (Figure 1.4) were considered to be bifunctional catalyst for the 
strong acid site of OH proton and Lewis basic site from the phosphoryl oxygen. The pKa values 
of phosphoric acids range from 2 to 4 in DMSO13, which is believed to be enough to protonate 
the substrates and form tight ion pairs between substrates and chiral phosphates. They employed 
BINOL as chiral backbone to deliver chirality and with the fine tune of bulky substituents at 3 
and 3’ position, the acidity as well as steric of the catalysts could be variable to fit different kinds 
of substrates. 
 
Figure 1.4 Chiral phosphoric acid 
Ever since the initial reports, the concept of forming chiral ion pairs using phosphoric acids 
has been widely accepted, and chiral phosphoric acid catalysis has been applied in many 
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asymmetric carbon-carbon bond, carbon-heteroatom bond formation as well as oxidation and 
reduction reactions.14 
1.4 Pinacol rearrangement 
Note to the Reader: Some of the work in this chapter has been previously published and is 
utilized here with the permission of the publisher. 
The conversion of cyclic or acyclic vicinal diols to ketones or aldehydes, catalyzed by 
Brønsted acids or Lewis acids, through dehydration followed by [1,2]-alkyl, [1,2]-aryl or hydride 
shift is known as Pinacol rearrangement (Scheme 1.7).15 It was first reported by Fittig in 1860 
that employing sulfuric acid with 2,3-dimethylbutane-2,3-diol, so called Pinacol, gave 3,3-
dimethylbutane-2-one.16 The widely accepted mechanism is as follows: one of the hydroxyl 
groups gets protonated by acid, which results in the loss of one molecule of water to give the 
carbocation intermediate. Because of the character of carbocation, this intermediate seeks a 
[1,2]-shift to afford a more stable carbocation. After the proton is lost from the other hydroxyl, 
the product is formed. 
 
Scheme 1.7 Pinacol rearrangement 
R2
HO
R1
R3
OH
R4
R2
HO
R1
R3
R4
R2
R1
R3
OH
R4
and/or
R1
O
R4
R2R
3
R4
O
R1
R3R
2
and/or
carbocation intermediate ketone or aldehyde
Brønsted acids 
or Lewis acids
- H2O
 11 
As a unique strategy of re-constructing carbon-carbon bonds, especially in ring expansions 
and contractions, the Pinacol rearrangement shows its usefulness in many natural products 
synthesis. In Pettit and co-worker’s hydroxyphenstatin synthesis,17 a BF3-mediated Pinacol 
rearrangement of a vicinal diol to afford a substituted aldehyde was the key step (Scheme 1.8). 
 
Scheme 1.8 Synthesis of hydroxyphensatatin 
In the total synthesis of (±)-furoscrobiculin B, which has antibacterial activities, Suemune 
and Kanematsu used a ring expansion Pinacol rearrangement as the key step.18 The secondary 
hydroxyl on the tricyclic furan ring was converted to the corresponding tosylate and went 
through the rearrangement in situ to afford the ring-expansion product (Scheme 1.9). 
 
Scheme 1.9 Synthesis of (±)-Furoscrobiculin B 
Despite of some applications in the natural product synthesis, the regioselectivity of Pinacol 
rearrangement can vary because of the likelihood of multiple carbocation formation after the 
protonation, which makes the widespread usage suffer.19 While strategies exist where a stable 
carbocation or predictable carbocation can mitigate regioselectivity issues, most applications 
have relied upon a more general variant termed the semipinacol rearrangement.20 When one of 
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the hydroxyl groups from the vicinal diols is previously converted to a better leaving group, such 
as halides or tosylate, the generation of the carbocation intermediate becomes regioselective 
(Scheme 1.10). This variant of Pinacol rearrangement is referred to the semipinacol 
rearrangement. 
 
Scheme 1.10 Semipinacol rearrangement 
The regioselectivity and stereoselectivity of semipinacol rearrangement have always been 
intriguing research topics for organic chemists. In 2001, Dake and co-workers reported acid-
promoted stereocontrolled semipinacol reaction to construct azaspirocyclic ketones via the ring 
expansion of cyclobutanols (Scheme 1.11). 21 Brønsted acids such as CSA and HCl as well as 
Lewis acid were applied in the transformation and diastereomeric ratio was up to 14 to 1, which 
came from the pre-existing stereocenters on the substrates. 
 
Scheme 1.11 Stereocontrolled semipinacol rearrangement 
Tu and co-workers documented an enantioselective semipinacol rearrangement of 2-oxo 
allylic alcohols in the presence of catalytic amount of TRIP or TRIP silver salt in 2009.22 The 
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best catalyst was found to be silver TRIP phosphate. And this ring-expansion semipinacol 
reaction afforded spiroethers containing one chiral oxo quaternary carbon stereogenic center in 
up good yields and enantiomeric excess (Scheme 1.12). 
 
Scheme 1.12 Enantioselective semipinacol rearrangement of 2-oxo allylic alcohols 
In the same year, Tu reported another semipinacol rearrangement of vinylogous α-ketol 
mediated by cinchona-derived catalyst.23 The all-carbon quaternary stereocenters in spirocyclic 
diketones were yielded with good enantioselectivity (Scheme 1.13). 
 
Scheme 1.13 Enantioselective semipinacol rearrangement of vinylogous α-ketol 
1.5 Chiral phosphoric acid-catalyzed asymmetric Pinacol rearrangement 
Although with the presence of a more predictable carbocation position, semipinacol 
rearrangement has shown its synthetic utility, the pre-installation of the better leaving group or 
selective replacement of one hydroxyl group from the diol can be the synthetic detour and create 
difficulties in designing and executing the synthesis of target compounds. Moreover, due to the 
significance of the enantioselectivity, the development of asymmetric variant of Pinacol 
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rearrangement is in high demand. However, to the best of our knowledge, no example of a 
catalytic enantioselective Pinacol rearrangement has been reported to date. For these reasons, 
predictable and stereoselective variants of the direct Pinacol rearrangement are highly desired 
and interesting. 
Because of the recent and relatively wide spread applications of chiral phosphoric acids as 
catalysts for asymmetric transformations, it occurred that the Pinacol rearrangement, has already 
known to be catalyzed by Brønsted acids, could be controlled through a catalytic enantioselective 
process mediated by chiral phosphoric acids.  
The regioselectivity of the rearrangement would be imperative and that a transformation of 
this type would be largely substrate dependent. We began the investigation by applying the 
phosphoric acids to an indolyl diol 1a, based on the hypothesis that phosphoric acids could 
mediate the dehydration of 1a and access to the desired iminium intermediate, which formed ion 
pair with the corresponding phosphate (Figure 1.5). Similar intermediate was reported by 
Rueping24a for the Friedel-Crafts addition of indoles to β,γ-unsaturated α-keto esters, You24b for a 
tandem double Friedel-Crafts reaction and by Gong24c for the asymmetric alkylation of 
enamides. The intermediate then could undergo a [1,2]-shift to furnish the Pinacol 
rearrangement. 
 
Figure 1.5 Hypothesis of phosphoric acid-catalyzed Pinacol rearrangement 
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The encouraging results were obtained that when racemic BINOL-phosphoric acid was 
applied, the Pinacol rearrangement product 2a did form with 60% yield. And when chiral 9-
anthracenyl BINOL-phosphoric acid was used as catalysis, 2a was separated with 32% ee along 
with 43% yield. This preliminary result encouraged us to evaluate additional BINOL-based 
chiral phosphoric acids as catalysts (Table 1.1). 
Table 1.1 Catalysts survey of asymmetric Pinacol rearrangement 
 
As shown in Table 1.1, the BINOL-based chiral phosphoric acids show the activities in 
promoting the Pinacol rearrangement of 1a in DCM at room temperature. 4Å MS was added to 
remove the H2O that formed during the process. The chiral acids with bulky substituents at 3,3’-
possision of BINOL gave low yield and low enantioselectivities (entry 1-3). TRIP acid (PA4) 
N
Bn
HO OH
Ph
Ph
N
Bn
∗
Ph O
PhPA (10 mol%)
DCM, 4Å MS, rt
1a 2a
O
O P
O
OH
PA1, R=9-anthracenyl
PA2, R=9-phenanthryl
PA3, R=Ph3Si
PA4, R=2,4,6-(iPr)3C6H2
PA5, R=2-naphthyl
PA6, R=1-naphthyl
PA7, R=3,5-(CF3)2C6H3
PA8, VAPOL-PA
PA9, R=2,4,6-Me3C6H2
PA10, R=4-Tolu
PA11, R=Ph
PA12, R=4-CF3C6H4
R
R
Entry[a] PA Time [h] Yield [%][b] ee [%][c]
1 PA1 72[d] 43 32
2 PA2 72[d] 38 7
3 PA3 72[d] 63 10
4 PA4 4 84 40
5 PA5 72 85 17
6 PA6 72 88 60
7 PA7 28 77 3
8 PA8 72[d] 55 0
[a] Reaction conditions : DCM (0.1 M), 4Å molecular sieves (MS). [b]Isolated
yields. [c] The enantiomeric excess was determined by HPLC analysis.
[d] Reaction was quenched at 72h. [e] Reaction ran in DCE.
9[e] PA9 48 86 22
10 PA10 72 48 0
11 PA11 20 93 0
12 PA12 19 94 8
O
O P
O
NHTf
PA13
13 PA13 1 95 4
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gave good yield in 4 hours, however the ee was still not satisfactory (entry 4). Along the survey, 
1-naphthyl-BINOL-PA (PA6) turned to better than others to be the catalyst regarding of both 
yield and enantioselectivity. Based on the same steric as PA6, a stronger acidic variant (PA13) 
was synthesized and applied to the reaction. Although the reaction processed in a much faster 
fashion, the ee dropped significantly (entry13). This showed the acidity of phosphoric acid alone 
is sufficient for this rearrangement, and stranger acid did not form tight ion pair intermediate, 
which was vital in the transformation. 
One of the advantages of using BINOL as chiral backbone is the large variety of derivatives. 
Since moderate ee was obtained by BINOL-based phosphoric acids, fine-tuning the dihedral 
angle of the chiral backbone could lead to more suitable steric situation and higher 
enantioselectivity. H8-BINOL, the partially hydrogenated scaffold was used as the chiral 
backbone, and three phosphoric acids were synthesized and applied onto the asymmetric Pinacol 
reaction. 
Methyl-protected indolyl diol 1b was chosen, and the reactions were preformed in toluene in 
the presence of H8-BINOL-PAs. The steric change of the chiral backbone did give positive 
effect on the reaction efficiency and enantioselectivity (Table 1.2). 1-naphthyl-H8-BINOL-PA 
was found to be the best catalyst for this transformation, with 92% ee in toluene (entry 1). Other 
H8-BINOL based phosphoric acids also showed better enantioselectivities that the corresponding 
BINOL ones (entry 2,3). 
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Table 1.2 H8-BINOL-phosphoric acids as catalysts 
 
With the best catalyst in hand, a solvent survey was performed to determine the adaptability 
of the reaction to different solvents and the best solvent (Table 1.3). 
Table 1.3 Solvent survey of asymmetric Pinacol rearrangement 
 
N
Me
HO OH
Ph
Ph
N
Me
∗Ph
O
PhPA (10 mol%)
Toluene, 4Å MS, rt
1b 2b
O
O P
O
PA14, R=1-naphthyl
PA15, R=2,4,6-(iPr)3C6H2
PA16, R=Ph
R
R
Entry[a] PA Time [h] Yield [%][b] ee [%][c]
1 PA14 0.5 88 92
2 PA15 24 92 83
3 PA16 4 88 86
[a] Reaction conditions : Solvent (0.05 M), 4Å molecular sieves (MS). 
[b]Isolated yields. [c] The enantiomeric excess was determined by HPLC 
analysis.
OH
N
Me
HO OH
Ph
Ph
N
Me
∗Ph
O
PhPA (10 mol%)
Solvent, 4Å MS, rt
1b 2b
O
O P
O
PA14, R=1-naphthyl
R
R
Entry[a] PA Time [h] Yield [%][b] ee [%][c]
1 PA14 92 92
2 PA14 5 93 92
3 PA14 18 78 89
4 PA14 18 84 89
5 PA14 12 80 91
[a] Reaction conditions : Solvent (0.05 M), 4Å molecular sieves (MS). [b]Isolated yields. [c] The 
enantiomeric excess was determined by HPLC analysis. [d] 5 mol% PA14. [e] 2.5 mol% PA14. 
[f] 1 mol% PA14.
6 PA14 5 93 94
7 PA14 4 94 95
8 PA14 4 94 96
9 PA14 18 60 95
5
Solvent
Toluene
o-Xylene
Diethyl ether
Isopropyl acetate
TBME
Benzene
Benzene[d]
Benzene[e]
Benzene[f]
OH
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In the presence of catalyst PA14, the asymmetric Pinacol rearrangement of 1b can tolerant a 
variety of different polar and non-polar solvents. The aromatic solvents such as toluene (entry 1), 
o-xylene (entry 2) and benzene (entry 6) are suitable for the transformation. Ether solvents 
(entries 3 and 5) and ester (entry 4) are all work, with slightly lower yields and lower ee. 
Benzene was found to be optimal for the reaction, since the enantioselectivity was better than 
others. Interestingly, lowering the catalyst loading provided a positive effect, with respect to both 
yield and enantioselectivity (entries 6-8); albeit with reduced rate when 1 mol % of catalyst was 
used (entry 9). 
The effect of the temperature was investigated. Decreasing the temperature of the reaction to 
0°C caused the enantioselectivity to decrease to 91% ee with 91% yield (vs 96% ee and 94% 
yield at room temperature). This means low temperature suppressed the catalytic pathway of the 
reaction more than the nonselective background pathway. Besides, increasing the temperature to 
40°C also had negative effect on the reaction, with 89% ee and 92% yield obtained. Higher 
temperature than room temperature boosted the background pathway more than the 
enantioselective catalytic pathway. 
The enantioselective transformation worked with 3Å, 4Å and 5Å MS, with 95%, 96%, 94% 
ee respectively. The role of the MS was determined to be the drying agent that absorbed water 
during the reaction. Without the MS, low yield and ee was observed. And changing MS to other 
drying agent, such as anhydrous Na2SO4, low yield (65%) and low ee (82%) was obtained. The 
optimal reaction conditions for this asymmetric Pinacol rearrangement of indolyl diol were 
determined to be using benzene as solvent, at room temperature, in the presence of 4Å MS and 
2.5 mol% of the catalyst 1-naphthyl-H8-BINOL-PA. 
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Table 1.4 Substrate scope of asymmetric Pinacol rearrangement 
 
With the optimal reaction conditions in hand, the substrate scope of the newly developed 
pinacol rearrangement was assessed (Table 1.4). 2.5 mol % of catalyst PA14 was used to ensure 
reaction completion. A lower catalyst loading would presumably be tolerated in individual cases. 
The reaction is tolerant towards the indole-protecting group, with regard to enantioselectivity as 
well as reaction efficiency. Methyl, benzyl, or allylic substitution of the 1-position of the indole 
resulted in high enantioselectivity (94-96% ee) for each rearrangement (entries 1-3). The 
electronics of the aryl migrating group were next evaluated. Electron-withdrawing (entries 4 and 
5) and electron-donating substituents (entries 6 and 7) at the para position of the phenyl ring 
N
R1
HO OH
R2
R2 PA14  (2.5 mol %)
4 Å MS, benzene
1 2
R3
N
R1
R2
R3 R2
O
Entry[a] 2 yield (%)[b] ee (%)[c]
1 2a: R1 = Bn, R2 = Ph, R3 = H 84 95
2 2b: R1 = Me, R2 = Ph, R3 = H 94 96
3 2c: R1 = Allyl, R2 = Ph, R3 = H 88 94
4 2d: R1 = Me, R2 = 4-FC6H4, R3 = H 90 94
5 2e: R1 = Me, R2 = 4-ClC6H4, R3 = H 99 93
6 2f: R1 = Me, R2 = 4-MeC6H4, R3 = H 99 96
7 2g: R1 = Me, R2 = 4-MeOC6H4, R3 = H 97 91
8 2h: R1 = Me, R2 = 3,5-Me2C6H3, R3 = H 94 93
9 2i: R1 = Me, R2 = 2-naphthyl, R3 = H 93 93
10 2j: R1 = Me, R2 = Ph, R3 = F 95 96
11 2k: R1 = Me, R2 = Ph, R3 = Cl 86 94
12 2l: R1 = Me, R2 = Ph, R3 = Br 86 96
13 2m: R1 = Me, R2 = Ph, R3 = Me 95 94
14 2n: R1 = Me, R2 = Ph, R3 = MeO 83 96
6 h, rt
[a] Reaction conditions : Benzene (0.05 M), 4Å molecular sieves (MS). 
[b]Isolated yields. [c] The enantiomeric excess was determined by HPLC 
analysis.
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provided a substrate that migrated efficiently to furnish a product with  high enantioselectivity. 
Notably, the more sterically hindered 2-naphthyl substituted diol 2i provided the desired 
rearrangement product with high yield and enantioselectivity, although a longer reaction time 
was required (entry 9). Investigation into the effect of substitution on the indole ring revealed the 
reaction to be highly versatile to both electron-withdrawing and electron-donating groups at the 
5-position, providing products with high enantioselectivities (entries 10-14).  
Figure 1.6 illustrates a plausible mechanistic pathway detailing the chiral phosphoric acid 
induced dehydration of indolyl alcohol 1b followed by subsequent pinacol rearrangement. 
Intermediate A results from hydrogen bonding interactions of the bifunctional chiral phosphoric 
acid catalyst with diol 1b. Dehydration of intermediate A would presumably give rise to iminium 
intermediate B, which possesses potential 2-point binding with the chiral phosphate through 
hydrogen bonding and electrostatic interactions. Subsequent rearrangement via a [1,2]-aryl shift 
would furnish product 2b, with regeneration of the chiral phosphoric acid catalyst. 
 
Figure 1.6 Proposed mechanism for PA-catalyzed asymmetric Pinacol rearrangement 
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1.6 Conclusions 
In summary, we have disclosed the first catalytic enantioselective Pinacol rearrangement. 
Chiral phosphoric acids are utilized as highly efficient Brønsted acids in transforming indolyl 
diols to chiral α-indolyl ketones with high yield and enantioselectivity. The best catalyst was 
found to be a variant of BINOL-backbone phosphoric acid, 1-naphthyl-H8-BIOL-PA. And the 
catalyst loading could be reduced to 2.5 mol% in benzene without sacrifice of yield and 
enantioselectivity. The asymmetric transformation tolerated variety of substituents on the 
migrating group as well as indole ring. The mechanism is proposed to involve protonating of 
hydroxyl and formation of ion pair between iminium cation and chiral phosphate, followed by 
the selective [1,2]-shift. And the absolute stereochemistry of product 2l was determined to be (R) 
by single-crystal X-ray diffraction analysis. 
Interestingly, during this investigation, different results were obtained when different batches 
of catalysts were applied, although all the rest of the reaction conditions remained the same. 
Further study was performed to find out the cause. This leaded to the discovery of contamination 
of chiral phosphoric acid by trace amount of alkaline metals in silica gel when column 
chromatography purification performed. The new discovery of alkaline metal phosphates 
introduced new activation of functional groups and brought new variants of chiral phosphoric 
acid catalysis, which will be detailed in chapter 2 and chapter 3. 
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Chapter 2 Chiral Alkaline Earth Metal Phosphate-Catalyzed hetero-Diels-Alder 
Reaction 
2.1 Chiral phosphoric acids and chiral metal phosphates, the real catalysts 
It was observed during the experiments on the development of enantioselective Pinacol 
rearrangement that different batches of catalysts purified by different methods leaded to different 
results regarding of both yield and ee. The “acid” catalysts, which were synthesized by 
phosphorylation of BINOL derivatives, followed by column chromatography purification 
showed less efficiency and lower enantioselectivity than the ones that treated with 6N HCl after 
the column purification. This observation appeared in all of the catalysts that were tried and table 
2.1 showed three of them as examples. 
Table 2.1 Asymmetric Pinacol rearrangement using different batches of catalysts 
 
N
Me
HO OH
Ph
Ph
N
Me
∗
Ph O
PhCatalyst (5 mol%)
Benzene, 4Å MS, rt
1b 2b
O
O P
O
OH
PA4, R=2,4,6-(iPr)3C6H2
PA6, R=1-naphthyl
R
R
Entry[a] Catalyst Time [h] Yield [%][b] ee [%][c]
1 PA4 purified on silica gel 84 44
2 PA4 washed with HCl 6 91 75
3 PA6 purified on silica gel 72 88 60
4 4 92 78
5 48 85 63
6 PA14 washed with HCl 4 94 96
[a] Reaction conditions : Benzene (0.1 M), 4Å molecular sieves (MS). [b]Isolated
yields. [c] The enantiomeric excess was determined by HPLC analysis.
O
O P
O
OH
PA14, R=1-naphthyl
8
PA6 washed with HCl
PA14 purified on silica gel
7 PA14 purified on silica gel twice 48 64 56
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After column purification, TRIP acid afforded the rearrangement product with 84% yield and 
only 44% ee in 8 hours (entry 1). However, if the TRIP used in entry 1 was washed with 6N HCl 
and applied to the substrate 1b, 91% yield of the product was obtained in 6 hours, with the ee 
raised to 75% (entry 2). Similarly, the column purified 1-naphthyl-BINOL-PA (PA 6) yielded 
the 88% of the product with 60% ee, and the same catalyst washed by HCl gave 78% ee in a 
short reaction time (entries 3 and 4). For the optimal catalyst PA 14, big differences of ees and 
reaction times were shown between the catalysts purified by column and re-acidified by HCl 
(entries 5 and 6). Moreover, if PA 14 was purified on silica gel twice before applied to the 
reaction, the yield and ee further dropped than purification on silica gel once. This indicated the 
catalysts before and after treating with HCl were different, or contamination happened in either 
way of the purification. NMR spectra were used to analysis the catalysts. Although the 
integrations of the aromatic areas were the same, some differences of chemical shift were 
observed comparing the spectra of catalysts before treating HCl and after. 
During the investigation of finding out the real catalysts for the Pinacol rearrangement, other 
groups also found similar results. Ishihara1 found out the possible salt formation and 
contamination of BINOL-phosphoric acids during purification on silica gel, and he also realized 
that those impurities might have a substantial influence on the performance of the acid catalysts 
(Table 2.2). 
They reported the significance of the acidic washing of chiral phosphoric acids after column 
chromatography purification. And, not only chiral phosphoric acid (H[P]) but also chiral metal 
phosphates (Table 2.2) catalyze enantioselective Mannich reactions of aldimines with 1,3-
dicarbonyl compounds (e.g. acetylacetone). 
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Table 2.2 Contamination of phosphoric acid during purification on silica gel 
 
Moreover, Ca[P]2 was most effective for the enantioselective Mannich-type reaction, and its 
result was closed to the one got from chiral phosphoric acid with purification on silica gel. This 
work showed the facticity of the contamination when performing purification on silica gel as 
well as the contamination can be the “true” catalyst and more effective than phosphoric acid on 
asymmetric transformations. 
Following Ishihara’s lead, List2 re-evaluated his TRIP catalyst. He confirmed the presence of 
partial phosphate salts when the re-acidification (washing with HCl) of the catalyst was not 
conducted. A quick test with pH paper was applied, the solution of TRIP that was re-acidified by 
HCl gave a pH of ca. 1-2 in methanol, while TRIP purified by column without washing with acid 
was only mildly acidic with a pH of around 5. With the help of trace element analysis of the 
TRIP purified on silica gel by ICP-OES, the existence of various alkali and alkaline earth metals 
was revealed to be present as major impurity, with the presence of several other metals (Table 
2.3). The TRIP that re-acidified by HCl revealed only traces of metal impurities apart from 
silicon, which supported that it was free acid. 
Ph
N
H
Boc
+ O O
Ph
NH
Ac
Ac
Boc
Catalyst (2-5 mol %)
CH2Cl2, 1h, rt
Ar
Ar
O
O
P
O
O M
n
M[P]n (Ar = 4-(2-Naph)-C6H4
            M = H, Li, Na, Mg, Ca, Sr)
Catalyst (mol %) Yield (%) ee (%) Config.
Li[P] (5) 11
Na[P] (5) 88 9
Mg[P]2 (2.5) >99 43
92
>99 59
H[P] purified on silica gel (2) 86 92
99
Ca[P]2 (2.5)
Sr[P]2 (2.5)
(S)
(S)
(R)
(R)>99
(R)
(R)
H[P] washed with HCl (2) 88 27 (S)
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Table 2.3 Trace element analysis of TRIP by ICP-OES 
 
The two pioneer works indicated the alkali and alkaline earth metal phosphates formed 
during the purification process of making the catalysts and their catalytic activity as 
enantioselective catalysts alone. Comparing my observation of the catalysts performance to their 
discoveries, it was possible my catalysts got contaminated during the purification over silica gel, 
which decreased the catalytic activity and the performance of catalyst could get back after 
washed with hydrochloric acid. In order to confirm the alkali and alkaline earth metal phosphates 
were not active catalysts for asymmetric Pinacol rearrangement, a series of chiral metal 
phosphates were prepared and applied to the reaction, along with the chiral acid after re-acidified 
by HCl (Table 2.4). Although all the catalysts had the some catalytic activity towards the 
enantioselective reaction and all the configurations of the products were the same, the alkali 
metal, such as Li and Na, phosphate gave poor yields and ees. Moderate ees were obtained with 
alkaline earth metal phosphates. The catalyst purified directly on silica gel gave similar result 
with Mg and Ca phosphates. The best result was observed with re-acidified catalyst. 
This quick comparison showed the real acid that re-acidified by strong acid (such as HCl) 
was the true catalyst for asymmetric Pinacol rearrangement. Besides, the similar results observed 
by using Mg, Ca phosphates and catalyst purified on silica gel indicated the majority of the 
contaminations during the column chromatography purification were Mg and Ca phosphates. 
Batch Na K Mg Ca Al Si Fe Pd Zn
Purified on silica gel 6151 29 3590 7482 <5 560 15 7 5
Washed with HCl 16 13 20 83 20 725 9 <5 <5
Values in ppm
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Table 2.4 Asymmetric Pinacol rearrangement: real acid 
 
2.2 Chiral metal phosphates 
Although the applications of phosphoric acids as organocatalysts have been fruitfully 
developed in the resent years, they were initially employed as ligands with metals during the 90s. 
Paired with metals, BINOL phosphate complexes have the Lewis acid position in place of the 
Brønsted acidic site at the phosphoric acid moiety, allowing these complexes to take part in a 
large variety of reactions. And the P=O moiety from the counter ion phosphate, can act as a 
Lewis base that can active the nucleophiles (Figure 2.1). Similar to the phosphoric acid 
chemistry, the ion pair that formed with Lewis acid complex and the chiral phosphate delivers 
the chirality to the product. 
 
Figure 2.1 Chiral metal phosphates 
Ar
Ar
O
O
P
O
O M
n
M[P14]n (Ar=1-naphthyl
            M = H, Li, Na, Mg, Ca)
Catalyst Yield (%) ee (%) Config.
34
36 12
83 62
65
45 36
H[P14] purified on silica gel 85 63
56 (R)
(R)
(R)
(R)86
(R)
(R)
H[P14] washed with HCl 94 96 (R)
N
Me
HO OH
Ph
Ph
N
Me
∗
Ph O
PhCatalyst (5 mol%)
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1b 2b
Li[P14]
Na[P14]
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Ca[P14]
Sr[P14]
X
X
O
O P O
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n
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The application of metal phosphate can root back to 1990, when Alper3 reported the 
synthesis of arylpropionic acids mediated by palladium with BINOL-phosphate as chiral ligand 
(Scheme 2.1). The enantioselectivity reached to 91%ee with the simple BINOL-phosphoric acid. 
Although no catalytic cycle was proposed, it was believed a palladium phosphate must be 
involved. 
 
Scheme 2.1 Synthesis of arylpropionic acids using Pd-Phosphate 
Followed by this, Pirrung4 showed cycloaddition reactions of diazoccompounds catalyzed by 
Rhodium phosphate with 50% ee in 1993. Inanaga5 published a Diels-Alder reaction by 
Ytterbium phosphate in 1995.  
During the investigation of chiral phosphoric acids catalysts introduced by Akiyama and 
Terada, many enantioselective transformations catalyzed by chiral metal phosphates also 
emerged6. Varity of metals, such as Scandium7, Cerium8, Sodium9, Iridium10, Copper11, 
Palliduim12, and Silver13, revealed great activity towards various asymmetric reactions combined 
with chiral phosphates. 
Due to the involvements of both transition metals and chiral phosphates, the concept of chiral 
metals phosphate chemistry opened new routes to design enantioselective transformation beyond 
the organocatalysis, transition-metal catalysis, and Lewis acid catalysis. Despite a privileged 
catalyst the phosphoric acid has proven to be, the vast majority of its application is imine 
activation, because the acidity of BINOL-PA is suitable for protonating imines to form ion pair, 
RHC CH2 + CO + H2O RCH(CH3)COOH
O2, THF, BINOL-PA
PdCl2, CuCl2, HCl, 
rt, 1 atm yield up to 89%
ee up to 91%
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the activation of other functional groups were still limited. The development of chiral metal 
phosphates fulfilled the gap and broadened the application of chiral phosphate chemistry. 
2.3 Chiral alkaline metal phosphates 
Alkaline earth metals, such as magnesium and calcium are naturally abundant, fairly 
inexpensive, and relatively nontoxic. In terms of the application of alkaline earth metal 
complexes to organic transformations as catalysts, the low electronegativity advantages them to 
be good Lewis acids. And stable oxidation state the metals sustained at +2 ensures the stability of 
the corresponding catalysts. Moreover, the metals’ relatively large ionic radius and multiple 
coordination sites not only exhibit the possibility of activating a variety of functional groups, but 
also have enough space for the chiral ligands or chiral counter ions to be involved in the reaction 
center and control the enantioselectivity. 
Despite of the advantages of alkaline metals complexes as catalysts, their appearance in 
organic synthesis is still fairly infrequent, and the applications their respective metal catalysts in 
transformations are relatively rare.14 Recently, the discovery of the contamination of chiral 
phosphoric acids by purifying over silica gel, and the formation of alkaline earth metal 
phosphates thereafter have drawn attention. The highly alterable in terms of the metals and chiral 
phosphates and the very Lewis acid character of the complexes are the advantages of using chiral 
alkaline metal phosphates (such as Ca and Mg) as catalysts. Presumably by means of ion pairing 
the cationic intermediate with chiral phosphate anions, high enantioselectivities were observed in 
many reactions1,2,15,16 when alkaline earth metal phosphates served as mild catalysts. 
Ishihara and List’s work1,2 as well as others17 showed the reactivity of Calcium phosphates 
towards imines. In 2011, our group15,16 reported enantioselective chlorination and oxidation of 
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BOC-protected oxindole catalyzed by VAPOL calcium phosphate (Scheme 2.2). In the 
chlorination, excellent yields and enantioselectivities were observed in the presence of the 
catalyst when NBS was used for providing the Cl cation. And in the oxidation, benzoyl peroxide 
oxidized the active intermediate that was formed by oxindole with VAPOL Ca phosphate. 
 
Scheme 2.2 Chlorination and oxidation of oxindole catalyzed by VAPOL Ca phosphate 
The success of our previous work indicated the 1,3-dicarbonyl coordination and activation 
from Calcium phosphate (Figure 2.2 left). The calcium coordinated with the 1,3-dicarbonyl of 
acyl-protected oxindole (one carbonyl from oxindole, and one from acyl protecting group), and 
alone with phosphates counter ions, enantiomeric pure product was afforded when the other 
reaction partner was involved. As part of our ongoing efforts towards the development of new 
reactions catalyzed by chiral phosphoric acids and metal phosphates, we analyzed this 
intermediate and theorized an activation model in which alkaline earth metal phosphate may 
coordinate with 1,2-dicarbonyl compounds to activate one of the carbonyls (Figure 2.2, right).  
N
Boc
O
Ar
+
N
O
O
Cl
OPh
O
O Ph
O
or
N
Boc
O
Ar
Cl
N
Boc
O
Ar
O
Ph
O
up to 95% yield
up to 99% ee
up to 99% eeVAPOL Ca Phosphate
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Figure 2.2 Hypothesis 
Through this activation, chiral metal phosphates could promote reaction involving carbonyl 
groups, other than just imines. And this would bring new enantioselective reactions to the 
already fruitful field of chiral phosphoric acid and phosphate chemistry and grant the chemistry 
to be a more powerful tool in the asymmetric synthesis. 
2.4 Asymmetric hetero-Diels-Alder reaction of aldehydes and ketones 
The [4+2] cyclization of a diene and a dienophile to afford a cyclohexene product is well 
known as the Diels-Alder cycloaddition (DA reaction). If one or more of the carbon atoms in 
either diene or dienophile are replaced by other heteroatoms, the reaction is referred to as the 
hetero Diels-Alder reaction (HDA) (Scheme 2.3). 
 
Scheme 2.3 Diels-Alder reaction and hetero-Diels-Alder reaction 
The catalytic enantioselective hetero-Diels-Alder (HDA) reaction18 is arguably the most 
powerful way of constructing six-membered heterocycles bearing a chiral tertiary or quaternary 
carbon center in a single step from commercially available substrates. Indeed, the most typical 
N
O
O
R2O
M
O O
O
O
P
OO*
H P
OO
*
M
O O
O
O
P
OO*
P
OO
*
R2O
O
R1
O
R1
R1 +
R2 R2
R1 Diels-Alder reaction
b a
c d
+ e
f
b
c d f
ea
Hetero-Diels-Alder reaction
a,b,c,d,e,f are not all carbons
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products involving carbonyl compounds are tetrahydropyran derivatives, which occur frequently 
in the structural motifs of biologically active natural products.19 
In the development of catalytic asymmetric HDA reactions, aldehydes have been the most 
employed dienophiles, which provide the access to variety of chiral six-membered heterocycles. 
Many types of catalysts have been introduced, including chromium, titanium, rhodium 
complexes as well as organocatalysts. 
In 1999, Jacobson20 disclosed the HDA reaction of aldehydes catalyzed by chiral salen-
Cr(III) complexes. Both aromatic and aliphatic aldehydes were suitable for the transformation 
and up to 99% ee was obtained (Scheme 2.4). Many other HDA reactions of aldehydes emerged 
after this, using Cr(III) as Lewis acid with chiral ligands.21 
 
Scheme 2.4 HDA reaction of aldehydes catalyzed by Cr salen complexes 
A number of chiral titanium catalysts have been used to promote asymmetric HDA reaction 
of aldehydes. As an example22, BINOL-titanium complexes showed their efficiency to catalyze 
Me
OR
Me + R1CHO
1) catalyst (3 mol%)
4Å MS,rt, 16-40h
2) TBAF, AcOH, THF
O
O
Me
Me
R1
R=TMS or TBS R1= Ph
CH2OTBS
n-C5H11
(CH2)4CH=CH2
CH2CH2Ph
CH2CH2NHBoc
2-furyl
up to 99% ee
(all cis)
O
N O
Me
Ad
Cr
X X=Cl or SbF6
catalyst
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HDA reaction between Danishefsky’s diene and aldehydes (Scheme 2.5). In Feng’s report, 
excellent enantioselectivities were observed with variety of aromatic aldehydes. 
 
Scheme 2.5 HDA reaction of aldehydes catalyzed by Ti-BINOL complexes 
The versatility of chiral dirhodium(II) carboxylate and carboxamidate catalysts has also 
benefited the HDA reaction. In particular, Doyle23 demonstrated asymmetric HDA reaction of 
aromatic aldehydes (Scheme 2.6). In the case of using Danishefsky’s diene, Rh2(4S-MPPIM)4 
turned out to be the optimal catalyst and high ee with good yield was obtained. 
 
Scheme 2.6 HDA reaction of aldehydes catalyzed by dirhodium complex 
Many other metal complexes, such as aluminum24a, zirconium24b, cobalt24c, manganese24d, 
zinc24e, copper24f, magnesium24g, also showed great applications on asymmetric HDA reaction of 
aldehydes. Besides using the metal catalysts, high enantioselectivity was also observed when 
organocatalysts were employed. As mentioned in chapter 1, Rawal discovered the high 
enantioselective HDA reaction of aldehyde using TADDOL as organocatalyst (Scheme 1.5). In 
2005, Yamamoto25 exhibited the activity of chiral 1,10-biaryl-2,20-dimethanol (BAMOL) 
scaffold towards the HDA reaction (Scheme 2.7). Excellent ees with good yields were obtained 
R1
O
H
+ R
2
OMe
TMSO
R3
OR3
R2
O
R1
1) Ti(Oi-Pr)4
(5-20 mol%)
(R)-BINOL
2) TFA
R1=Ar R2=H or Me
R3= Me or H
yield 70-99%
ee 83-99%
R
O
H
+
OMe
TMSO O
O
R1
1) Rh2(4S-MPPIM)4
    (1 mol%)
2) TFA
R=Ar yield 48-96%ee 82-95%
N N
O
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CO2Me
O 4Rh2
Rh2(4S-MPPIM)4
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when sterically and electronically tunable chiral diol catalyst was employed to promote the HDA 
reaction between 1-amino-3-siloxydiene (Rawal’s diene) and a wide range of aliphatic and 
aromatic aldehydes. 
 
Scheme 2.7 HDA reaction of aldehydes catalyzed by BAMOL 
Although asymmetric HDA reactions of aldehydes have been extensively studied, ketones 
substrates, in contrast, are much less reactive in HDA reactions due to electronic and steric 
properties, and are still challenging substrates for chemists.26,27 However, the demand of 
asymmetric ketone HDA reaction methodologies needs to be satisfied, for the extensive 
existence of the substructures as versatile building blocks for many biologically active 
compounds.  
In 1998, Jørgensen reported asymmetric HDA reaction of α-keto esters in the presence of 
copper-BOX Lewis acid catalyst (Scheme 2.8).26a,b The C2-symmetric bisoxazoline-copper(II) 
complex showed the potential to promote the reaction of several aromatic and aliphatic activated 
ketones, and the reaction could proceed with only 0.05 mol% of the catalyst without loss of 
selectivity. 
TBSO
NMe2
+
R
O
O
O
R
OH
OH
ArAr
ArAr
1)
Ar= 4-F-3,5-(Et)2-C6H2 (20 mol%)
-80°C, toluene
2) AcCl, CH2Cl2/toluene
R=Me, 75% yield, 97%  ee
R=Ph, 84% yield, 98% ee
R=m-MeOC6H4, 86% yield, 98% ee
R=o-O2NC6H4, 93% yield, 98% ee
R=1-Naph, 67% yield, 97% ee
R=2-Fu, 96% yield, 99% ee
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Scheme 2.8 HDA reaction of ketones catalyzed by Cu complex 
After Jørgensen’s initial report, progress has been made using Lewis acids such as Ti(IV)26f, 
Cu(I),27a as well as organocatalysts.27b In 2003, Inanaga26d succeeded in the development of 
novel chiral rare earth metal Yb complexes as catalysts for the asymmetric HDA reaction of 
ketones (Scheme 2.9). 
 
Scheme 2.9 HDA reaction of ketones catalyzed by Yb complex 
2.5 Catalytic asymmetric HDA reaction of ketones by chiral alkaline metal phosphates 
2.5.1 Asymmetric HDA reaction of α-keto esters 
Despite these creative efforts mentioned before, notable drawbacks still persist. For example, 
low enantioselectivities on substrates bearing bulky alkyl and aryl groups were observed in 
several methods, even after rigorous exclusion of air and moisture. Therefore, we would like to 
develop a more efficient asymmetric HDA reaction of ketones with broader substrate scope and 
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milder reaction conditions, which we believe could allow chemists an improved methodology for 
the synthesis. 
 
Figure 2.3 Chiral alkaline earth metal phosphates 
Based on the hypothesis we made previously, we initiated our investigation with the reaction 
of ethyl pyruvate 3a and trans-3-(tert-Butyldimethylsilyloxy)-1-methoxy-1,3-butadiene 
(Danishefsky’s diene) 4 in the presence of alkaline earth metal phosphates (Figure 2.3 The 
numbering of phosphates is corresponding to phosphoric acids in chapter 1, such as M[P1]2 is 
corresponding to PA1), started with racemic Mg phosphate. 
To our delight, the reaction proceeded smoothly to the product with 82% yield in DCM at 
room temperature and 5 mol% racemic Mg[P17]2 as catalyst (Table 2.5, entry 1). And no 
background reaction was observed without the presence of catalyst (entry 2). 
O
O P
O
O P(R)
Ar
Ar
Ph
Ph
O
O P(R)
M[P1]2: Ar= 9-anthryl
M[P2]2: Ar= 9-phenylanthryl
M[P4]2: Ar= 2,4,6-(iPr)3C6H2
M[P5]2: Ar= 2-naphthyl
M[P6]2: Ar= 1-naphthyl
M[P11]2: Ar= phenyl
M[P18]2: Ar= 2,6-(iPr)2-4-AdC6H2
M[P17]2 M[P8]2
O
O
O
O
O
O
M
2
2
2
M M
O
O P(R)
Ar
Ar
M[P14]2: Ar= 1-naphthyl
O
O
2
M
M= Mg or Ca
Ad=
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Table 2.5 Catalysts survey of asymmetric HDA reaction of ethyl pyruvate 
 
Then we evaluated different BINOL-based phosphate magnesium salts. The yield and 
enantiomeric excess depended largely on the substituents at the 3,3′-positions. Good yield was 
obtained with magnesium VAPOL phosphate Mg[P8]2 but in nearly racemic form (entry 3). A 
similar result was observed using less hindered magnesium phenyl-BINOL phosphate Mg[P11]2 
(entry 4). Alternatively, bulkier catalysts derived from 1-naphthyl (Mg[P6]2) and 9-anthryl 
(Mg[P1]2) afforded 5a in much higher ee, 64% and 84% respectively (entries 5 and 7). 
Interestingly, when catalysts which could provide similar steric (2-naphtyl vs 1-naphthyl, 9-
phenylanthryl vs 9-anthryl) were used, the ees dropped significantly (entries 6 and 8). The use of 
an H8-BINOL variant catalyst Mg[P14]2, which the corresponding acid is the optimal catalyst 
for asymmetric Pinacol rearrangement in chapter 1, also yielded the product with low 
enantioselectivity (entry 9). 
H3C
O
OEt
O
+
TBSO
OMe
O
H3C
OEt
O
O1) catalyst (5 mol%), 
rt, DCM
2) HCl
3a 4 5a
entry catalyst time (h) yield (%)[a] ee (%)[b]
1 Mg[P17]2 12 82 -
2 - 72 0 -
3 Mg[P8]2 24 90 -2
4 Mg[P11]2 19 93 13
5 Mg[P6]2 24 73 64
6 Mg[P5]2 24 72 -29
7 Mg[P1]2 24 92 84
8 72 50 40Mg[P2]2
9 Mg[P14]2 24 62 14
[a] Reaction conditions: 3a (1.0 equiv.), 4 (1.3 equiv.), 5 mol% 
catalyst in DCM (0.05 M). Isolated yield showed. [b] ee determined 
by HPLC analysis on chiral stationary phases.
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Considering the limited coordination sites alkaline earth metals have, trace amounts of water 
in the reaction system (from solvents or catalysts) may compete with the ethyl pyruvate for 
coordination to magnesium or calcium, so molecular sieves were added to the reaction to remove 
the water. Indeed, good yields and enantioselectivities were obtained after adding 4Å MS 
(entries 1-3 in Table 2.6). 
Table 2.6 Catalysts optimization of asymmetric HDA reaction of ethyl pyruvate 
 
Additionally, we found that the reaction proceeded more efficiently when calcium was used 
instead of magnesium with the amounts of calcium phosphate decreased to 2.5 mol% (entries 4 
and 5, Table 2.6). Improvement to 99% ee was achieved in the presence of 2.5 mol% calcium 1-
naphthyl-BINOL phosphate (Ca[P6]2) with 4Å MS at room temperature, with the reaction 
performed open to air (entry 4). 
H3C
O
OEt
O
+
TBSO
OMe
O
H3C
OEt
O
O1) catalyst (5 mol%), rt, 
4Å MS, Solvent, 16h
2) HCl
3a 4 5a
entry catalyst solvent yield (%)[a] ee (%)[b]
1[c] Mg[P6]2 DCM 67 64
2 Mg[P6]2 DCM 93 94
3 Mg[P1]2 DCM 97 84
4[d],[e] Ca[P6]2 DCM 95 99
5 Ca[P1]2 DCM 85 86
[a] Reaction conditions: 3a (1.0 equiv.), 4 (1.3 equiv.), 5 mol% catalyst, 
with solvent indicated 0.05 M and 4Å MS 20 mg/mL. Isolated yield 
showed. [b] ee determined by HPLC analysis on chiral stationary phases. 
[c] Reaction performed without MS. [d] Using 2.5 mol% catalyst. [e] 
Reaction performed open air.
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During the course of our studies, the solvent effect was also investigated (Table 2.7). With 
the reaction concentration was set to be at 0.05 mol/L, the reaction was found to tolerate several 
non-polar and polar solvents with the presence of MS (entries 1-5 in Table 2.7). 
Table 2.7 Solvent survey of asymmetric HDA reaction of ethyl pyruvate 
 
Aromatic solvent such as toluene gave lower ee than the chlorinated solvents, such as DCM, 
chloroform, and 1,2-dichloroethane (entries 1, 2, 4 and 5). Non-coordinating ether solvent (entry 
3) afforded the product 5a with good yield and ee at room temperature. In contrast with non-
coordinating solvents, the use of coordinating solvent such as THF and MeCN resulted in poor 
yields and low ees, even with the presence of MS (entries 6 and 7, Table 2.7). This poor 
performance possibly was due to competing coordination of the sites from solvents to calcium 
catalyst versus the sites from substrate. And methylene chloride was found to be the optimal 
H3C
O
OEt
O
+
TBSO
OMe
O
H3C
OEt
O
O1) catalyst (5 mol%), rt, 
4Å MS, Solvent, 16h
2) HCl
3a 4 5a
entry catalyst solvent yield (%)[a] ee (%)[b]
1[d],[e] Ca[P6]2 DCM 95 99
2[d] Ca[P6]2 Toluene 85 87
3[d] Ca[P6]2 89 91
4[d] 94 90Ca[P6]2
Diethyl ether
5[d] Ca[P6]2 1,2-DCE 91 93
CHCl3
6[d] Ca[P6]2 THF 65 56
7[d] Ca[P6]2 34 21MeCN
8 PA6 DCM 0 -
[a] Reaction conditions: 3a (1.0 equiv.), 4 (1.3 equiv.), 5 mol% catalyst, 
with solvent indicated 0.05 M and 4Å MS 20 mg/mL. Isolated yield 
showed. [b] ee determined by HPLC analysis on chiral stationary phases. 
[c] Reaction performed without MS. [d] Using 2.5 mol% catalyst. [e] 
Reaction performed open air.
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solvent for this transformation, with 99% ee and 95% yield observed (entry 1). To ruin out the 
possibility that phosphoric acid might be generated in this condition, and act as catalyst, we used 
PA6 instead of Ca[P6]2 to promote the reaction. Under the same reaction conditions, phosphoric 
acid PA6 did not catalyze the reaction, with respect to both yield and enantioselectivity (entry 8, 
Table 2.7). This clearly showed that calcium phosphates could activate the carbonyl group and 
reach high-level stereoselectivity. 
With the optimized conditions in hand, we next examined the scope of the transformation. 
Gratifyingly, a very wide range of α-keto esters with vastly different substitution provided high 
yields as well as high enantioselectivities in the reaction (Table 2.8). The α-keto esters with 
longer alkyl chain substitution, such as ethyl (3b), hexyl (3c) and phenethyl (3f), all gave high 
enantioselectivities, leading to the products bearing a variety of substituted quaternary carbon 
stereocenters. The sterically hindered iso-propyl group also provided a substrate that resulted in 
excellent yield and slightly lower ee (90%, 5d) for the reaction. Ethyl 3-phenylpyruvate (3e), 
which was used as a mixture of oxo/enol tautomers (about 5:1 ratio) due to the acidity of the α-
proton, formed the product in 91% yield with 99% ee (5e). When an unsaturated system was 
present in the substrate (3g), the diene can react with the carbonyl group selectively and leave the 
double bond untouched under the reaction conditions, with 98% ee (5g). Encouraged by this, we 
employed a α-keto ester with triple bond (3h). Again, the diene reacted with the carbonyl group 
even faster to form product with good yield and excellent ee (5h). Other useful functional groups 
could be obtained from further transformations of the alkene and alkyne of the products. 
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Table 2.8 Substrate scope for asymmetric HDA reaction of α-keto ester 
 
In order to empower the methodology and test the boundary of the substrate scope, the study 
of the aromatic substrates was important. Next we applied the optimal HDA reaction conditions 
for aliphatic α-keto esters to the aromatic substrates, despite their steric and electronic 
differences. Remarkably, excellent selectivity was also observed when ethyl benzoylformate was 
used as the substrate with direct phenyl substitution (Table 2.9, 3i). Different electron-
withdrawing and -donating substituents on para-position of the aromatic ring all furnished HDA 
products in high yields, regardless of their electronic properties, with excellent 
enantioselectivities (3j-m). The electronic factor from the phenyl substituents did not affect the 
enantioselectivities, which indicated the robustness of the catalytic system. The comparison of 
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O
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O
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O
R OEt
O
O1) Ca[P6]2 (2.5 mol%)
    4Å MS, rt, DCM, 12h
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H3C
O
O
OEt
O
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yield[a] 95%
ee[b],[c] 99%
Et
O
O
OEt
O
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O
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O
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yield[a] 94%
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Ph
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O
5g[d]
yield[a] 92%
ee[b] 98%
Ph
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O
5h[e]
yield[a] 76%
ee[b] 99%
TMS
[a] Reaction conditions: 3 (1.0 equiv.), 4 (1.3 equiv.), 2.5 mol% Ca[P6]2, in DCM 
(0.05 M) with 4Å MS 20 mg/mL. Isolated yield showed. [b] ee determined by HPLC 
analysis on chiral stationary phases. [c] The absolute configurations of 5a, 5d was 
determined by comparison of the optical rotations with literature values, and absolute 
configurations of all the other compounds were tentatively assigned by analogy. [d] 
Reaction time: 4 hours. [e] Reaction time: 1 hour.
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the reaction times between different substrates (3j-3m) showed the electron-deficient α-keto 
esters reacted faster than the electron-rich ones, which was consistent with fact that the LUMO 
of α-keto esters reacted with the HOMO of diene, and the energy of the LUMO was lower when 
electron-withdrawing group was attached. 
Table 2.9 Substrate scope for asymmetric HDA reaction of α-keto ester, continued 
 
The more sterically hindered 2-naphthyl-substituted α-keto ester (3n) provided the desired 
product with high enantioselectivity, although a longer reaction time was required. This was 
probably because the steric hindrance of the active intermediate (formed from substrate and 
catalyst) made little space for the diene to approach to the reaction center. But the hindered 
transition state did not affect the discrimination of enantiotopic faces to afford the enantiomeric 
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5o[e]
yield[a] 83%
ee[b] 98%
O
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5p
yield[a] 99%
ee[b] 99%
S
[a] Reaction conditions: 3 (1.0 equiv.), 4 (1.3 equiv.), 2.5 mol% Ca[P6]2, in DCM 
(0.05 M) with 4Å MS 20 mg/mL, Isolated yield showed. [b] ee determined by 
HPLC analysis on chiral stationary phases. [c] The absolute configurations of 5i 
was determined by comparison of the optical rotations with literature values. [d] 
Reaction time: 4 hours. [e] Reaction time: 48 hours.
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pure product. In addition, heteroaromatic rings like furan and thiophene were feasible partners in 
this transformation, giving the HDA products in good to high yields and excellent 
enantioselectivities (5o, 5p). The coordination sites of the furan and tiophene did not interfere 
with the enantioselectivity, although the reactivity was lower. The lower reactivity could be the 
consequence of the potential coordination from O and S to the catalyst, but one could still argue 
that the electron-rich character of those two substrates would lead to the lower reactivity because 
of the higher energy of their LUMOs. It is needed to mention that pyridine substrate was also 
tested with this catalytic system, however, low ee (~50%) was observed and the reaction could 
not finish in 4 days. The coordination could interfere the catalytic system, if it was very strong. 
In terms of lowering the catalyst loading, lower yield and enantioselectivity was obtained 
when 1 mol% of Ca[P6]2 was added instead of 2.5 mol%. Two explanations were suggested. The 
product that formed in the early stage could coordinate with the catalyst to prevent it from going 
to the next catalytic cycle. It is also possible that the product or even the large amount of α-keto 
ester in the reaction solution replace the chiral phosphate from the catalyst via coordination and 
ligand exchange. Either of the processes that suggested takes time to happen, obviously due to 
the kinetic fact. So if the catalytic reaction rate is much faster than the product coordination rate 
or the phosphate dissociation rate, the catalyst loading could be further reduced. 
2.5.2 Asymmetric HDA reaction of isatins 
Oxindoles bearing a chiral quaternary carbon center at the 3-position are important structural 
motifs present in alkaloid natural products as well as biologically active compounds. However, 
there is no example of obtaining this variant by a highly enantioselective HDA reaction of isatins 
at this moment. Isatin contains two carbonyl functional groups and they are 1,2 configuration, 
similar to the α-keto esters. Considering the similarity of α-keto ester with isatin, we turned our 
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attention to isatin, which could form oxindole with a spiro-carbon stereocenter after asymmetric 
HDA reaction. We chose to study benzyl-protected isatin due to its availability and ease in 
deprotection. 
We first applied the optimized conditions discovered previously (Table 2.10). 
Table 2.10 Asymmetric HDA reaction of isatin 
 
Pleasingly, isatin was consumed in less than 30 seconds and the HDA product was isolated 
with 98% ee at room temperature, despite the structural differences between isatins and α-keto 
esters (Table 2.10, entry 1). Diethyl ether was proved to be equally efficient in this 
transformation (entry 2), and the reaction finished in 30 seconds. The high reactivity showed the 
possibility of lowering the catalyst loading. As expected, enantioselectivity was still maintained 
N
Bn
O
O
R +
TBSO
OMe N
Bn
OR
O
O1) Ca[P6]2 (1 mol%)
    4Å MS, rt, DCM, 2min
2) HCl
6a-f 4 7a-f
entry R yield (%)[a] ee (%)[b]
1[c] H 95 98
2[c],[d] H 95 99
3[d] 95 99
4[d] 4-Cl 96 99[e]
5[d] 5-OMe 98 96
6 5-F 95 93
7 5-Cl 96 93
7
7a
7a
7a
7b
7c
7d
7e
8 5-Br 7f 95 93
9 6-Br 7g 96 97
10 7-Cl 7h 97 98
H
[a] Reaction conditions: 6 (1.0 equiv.), 4 (1.3 equiv.), 1.0 mol% catalyst, 
in DCM (0.05 M) with 4Å MS 20 mg/mL. Isolated yield showed. [b] ee 
determined by HPLC analysis on chiral stationary phases.[c] 2.5 mol% 
catalyst, reaction finished in 30s. [d] Reaction performed in diethyl 
ether. [e] The absolute configurations of 5b was determined by X-ray 
structure of the crystal, see supporting information.
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at a lower catalyst loading of 1 mol% with slightly longer reaction time (2 minutes, entry 3). The 
introduction of different substituents on the isatin core all provided products with good yields, 
irrespective of their steric nature (entries 3-9). Slightly reduced enantioselectivity was observed 
when electron-withdrawing groups were present in 5-position (Table 2.10, entries 5-7). 
2.5.3 Mechanistic studies 
In order to understand the role of the molecular sieves in the reaction, we performed a series 
of relevant experiments (Table 2.11). In the HDA reaction of benzyl-protected isatin 6a, different 
sizes of molecular sieves were used. The beneficial effect did not change while the size of 
molecular sieves increased (Table 2.11, entries 1-3). The reaction could happen without any 
catalyst, and product was isolated with 21% yield in 30 minutes (entry 4). 4Å MS could not 
promote the reaction significantly by itself, for a very similar amount of the product was 
obtained with the same reaction time when only MS was applied without Ca[P4]2 (entry 5). 
Catalyst Ca[P6]2 alone can afford the product with 93% yield and 92% ee (entry 6). These 
showed molecular sieves could just activate the catalyst in situ. To further confirm that high 
enantioselectivity can be observed without the presence of molecular sieves in the reaction, we 
let the catalyst and 4Å MS stir in diethyl ether for 5 minutes first, then removed the MS fast and 
carefully by filtration, followed by adding two substrates 6a and 4. High yield and 
enantioselectivity were back as well as the reaction rate (entry 7). Next, we did another 
experiment similar to entry 7, but added water back to the dried catalytic ether solution after 
removing the MS (2µL of water to 3.1mg of catalyst), then added the two substrates to react. As 
expected, the yield and ee dramatically diminished (entry 8). This proved our hypothesis that 
water can interfere the coordination between the catalyst and substrate, and the role of MS is 
removing the trace amounts of water (or MeOH, vide infra) in the catalyst. Also, the phosphoric 
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acid could not promote the reaction significantly with or without MS, since the product was 
obtained with similar yield and no ee (entries 9 and 10). So the phosphate and the ingredient of 
MS did not form ion pair, which may catalyze the reaction. 
Table 2.11 Molecular sieves studies 
 
Although some mechanistic proposals have been made, the actual alkaline earth metal 
phosphates structural evidence and its elucidation is still absent, and this prevents exploration of 
the transition state and new activation development. To address this issue, after a series of 
intensive experiments, a crystal of the catalyst Ca[P6]2 was obtained from the same conditions 
+
TBSO
OMe
1) conditions, rt, ether, 
30 min
2) HCl
4
entry catalyst (1 mol%) Molecular sieves yield (%)[a] ee (%)[b]
1[c] Ca[P6]2 95 99
2[c] Ca[P6]2 4Å MS 95 99
3[c] Ca[P6]2 5Å MS 95 99
4 no no 21 0
5 no 4Å MS 20 0
6 Ca[P6]2 no 93 92
7[c],[d] Ca[P6]2
8[d],[e] 43 68
9 PA6 no 21 0
3Å MS
N
Bn
O
O
6a
N
Bn
O
O
O
7a
4Å MS 94 98
Ca[P6]2 4Å MS/ water
10 PA6 4Å MS 22 0
[a] Reactions were performed with 6a (1.0 equiv.), 4 (1.3 equiv.) 
in diethyl ether (0.05 M) and other conditions indicated from each 
entry. If not specified, all entries were stopped at 30 minutes. 
Isolated yield showed. [b] ee determined by HPLC analysis on 
chiral stationary phases. [c] Reaction finished in 2 minutes. [d] 
4Å MS was filtered off before substrate was added. [e] 2µL of 
water was added after removing MS.
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that it was prepared (DCM and MeOH as solvents). Then its structure was examined by X-ray 
crystal structure analysis (Figure 2.4). 
 
Figure 2.4 ORTEP representation of Ca[P6]2 (hydrogen atoms are omitted for clarity; 
ellipsoids drawn at 50% probability level). 
Interestingly, both of the chiral phosphates are monodentate rather than bidentate to the 
calcium ion. The calcium ion possesses distorted octahedral geometry with two phosphates and 
four methanol molecules. The bond length of Ca1-O5 is 2.277(7) Å, which is shorter than Ca1-
O9 bond (2.349(8) Å) from Methanol. This shows the negative charge of the phosphate oxygen 
helps form stronger interaction with calcium ion. The P1-O3 bond length is 1.476(8) Å and it is 
approximately equal to P1-O4 bond (1.480(7) Å). The bond angle of O3-P1-O4 is 119.5(4) and 
the distance between P1 and Ca1 is 3.546(3) Å, which, along with Ca1-O4 bond length, explains 
the monodentate character of the phosphate from the geometrical point of view. 
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Next, Raman spectroscopy analysis was used to probe the interaction between 1,2-dicarbonyl 
substrate and catalyst (Figure 2.5): (1) Methylene chloride background, (2) benzyl-protected 
isatin 6a in methylene chloride, (3) Ca[P4]2 in methylene chloride and (4) benzyl-protected isatin 
6a and Ca[P4]2 (1:1) in methylene chloride.  
 
Figure 2.5 Raman spectra 
In methylene chloride (0.1 M), both carbonyl vibrations of benzyl-protected Isatin 6a show 
up on Raman spectrum. The ketone carbonyl vibration shows up at 1739 cm-1 (a in Figure 4, lit. 
IR value: 1737 cm-1) and the wavenumber for amide carbonyl is 1609 cm-1 (b in Figure 4, lit. IR 
value: 1605 cm-1). The catalyst Ca[P6]2 shows no peaks in the range of 1400 cm-1 to 2100 cm-1. 
When a solution of both 6a and catalyst Ca[P6]2 (1:1 molar equivalent) in DCM was tested, the 
vibrational frequency shifts were found for both of the carbonyls, from 1739 cm-1 to 1731 cm-1 
for ketone carbonyl (a’ in Figure 4) and 1609 cm-1 to 1572 cm-1 for amide carbonyl (b’ in Figure 
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4) respectively. The interference of the C=O bond vibrations indicates both of the carbonyls 
coordinate with the Calcium catalyst when they are mixing together. In addition, the decrease of 
the ketone carbonyl bond vibration energy suggests the C=O bond gets activated by 
coordination. 
On the basis of the catalyst structural information and Raman spectroscopy analysis, we have 
devised a transition state model to rationalize the observed enantioselectivity (Figure 2.6 and 
2.7). While molecular sieves remove water or methanol, the 1,2-dicarbonyl compounds would 
chelate with Calcium cation, with two phosphates providing a highly sterically hindered chiral 
environment. The bulky naphthyl group from the BINOL backbone disfavours the pathway 
towards the re face in the transition state (blocked face in Figure 2.6). On the other hand, the 
Danishefsky’s diene can attack from the less hindered si face (open face in Figure 2.6) to afford 
the corresponding products, which match the experimentally observed stereochemistry. 
 
Figure 2.6 Transition state model for observed absolute stereochemistry 
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Figure 2.7 Transition state model 
2.6 Conclusion 
In summary, we have developed highly enantioselective 1,2-dicarbonyl activation by 
applying alkaline earth metal phosphates as functional asymmetric catalysts. The 
enantioselective hetero-Diels-Alder reaction of α-keto esters with Danishefsky’s diene was 
described. The optimal catalyst was determined to be calcium 1-naphthyl-BINOL phosphate, and 
the catalyst loading could be down to 1 mol%. At room temperature, with the help of molecular 
sieves, excellent enantioselectivity (up to 99%) was observed with aliphatic, aromatic α-keto 
esters and isatins as substrates. The scope of this transformation is very broad, and the conditions 
are mild with high efficiency. This system is also proven to be effective on isatin substrates and 
this afforded the first example of highly asymmetric HDA reaction of isatins. 
Importantly, the structure of the catalyst was characterized, for the first time, by X-ray crystal 
structure analysis, and the chelation between substrates and catalyst was studied by Raman 
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spectroscopy analysis. The transition state described thereafter could provide considerable 
insight into the origin of enantioselectivity for HDA reaction. 
Moreover, the insightful mechanistic study could also aid the development of new 
asymmetric transformations, considering the generality of 1,2-dicarbonyl structure in the organic 
compounds and it compatibility with other functional groups. Other enantioselective 
transformations could be developed from this 1,2-dicarbonyl activation. 
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Chapter 3 Chiral Alkaline Earth Metal Phosphate-Catalyzed Mukaiyama-Michael 
reaction 
3.1 Mukaiyama-Michael addition 
The nucleophilic addition of carbanion or another nucleophile to electron-deficient double 
bond, usually an α,β-unsaturated carbonyl compound is well known as Michael addition. As one 
of the most useful methods for numerous carbon-carbon bond as well as carbon-hetero bond 
formation, many variants of this type of reaction exist. And the Lewis acid mediated addition of 
enol silanes to activated π-system is referred to Mukaiyama-Michael addition. 
Mukaiyama1 first reported titanium mediated addition of vinyl silyl ether to α,β-unsaturated 
ketones (Scheme 3.1). The transformation resulted in high yield of 1,5-dicarbony products, and 
this showed the application of enol silanes in Michael type addition. 
 
Scheme 3.1 Mukaiyama-Michael reaction mediated by titanium 
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Ph Ph
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O Ph
Ph
O1) TiCl4, DCM,
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3.2 Catalytic enantioselective Mukaiyama-Michael addition 
Because the enol silanes and silylketene acetals are considered to be the active surrogate for 
carbonyl compounds with α-proton, the Mukaiyama-Michael reaction becomes an efficient route 
to 1,5-dicarbonyl compounds.2 And the catalytic asymmetric variants of this process have been 
developed, for the synthetic economy of obtaining chiral 1,5-dicarbonyl compounds and their 
versatile derivatives. 
In 1999, Evans3 reported asymmetric Mukaiyama-Michael addition catalyzed by C2-
symmetric Cu(II) complex (Scheme 3.2). Aromatic and aliphatic alkylidene malonates both gave 
excellent yields and ees in hexafluoro-2-propanol (HFIP), when Cu-BOX complex was used as 
catalyst. The 1,3-dicarbonyl structure of malonate chelated with the Cu from the catalyst, and the 
chelated substrate formed a boat conformation with the copper atom at the apex. By the 
coordinated carbonyls from malonate, the BOX (bisoxazoline) ligand was distorted out of the 
plane. And this distortion was essential for induction of enantioselectivity. 
 
Scheme 3.2 Asymmetric Mukaiyama-Michael reaction catalyzed by Cu complex 
Later, the same group4 succeeded to expand this methodology to acylimide, another 1,3-
dicarbonyl structural Michael acceptor (Scheme3.3). Many derivatives of phenyl ketones, 
thioesters, and acylpyrroles with substituents could be used as the vinyl silyl ethers of the 
reaction. High yield with both diastereoselectivity and enantioselectivity was observed. The 
acylimide dicarbonyl structure was confined to promote the chelation to the copper catalyst, 
t-BuS
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Me Me
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catalystyield 88-99%ee 43-99%
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which was same as the previous work. And the model proposed before could also explain the 
stereochemistry. 
 
Scheme 3.3 Asymmetric Mukaiyama-Michael reaction of acylimide catalyzed by Cu 
complex 
Despite of the previous success in catalytic asymmetric variants of this process, new, more 
competent and practical catalytic methods with more substrate diversity are highly sought after. 
We wish to apply our 1,2-dicarbonyl activation on the enantioselective variant of Mukaiyama-
Michael addition by using alkaline earth metal phosphates. 
3.3 Catalytic asymmetric Mukaiyama-Michael reaction by alkaline earth metal phosphates 
The noteworthy chemoselectivity observed in the previous reaction of diene with β,γ-
unsaturated α-keto ester 5g favoring the carbonyl group drew our attention. With our catalytic 
system, high enantioselectivity was reached, although the reactant targeted the carbonyl group. 
However, if well designed, it is also possible that high enantioselectivity is observed when the 
reactant is targeting the activated double bond (β,γ-unsaturated double bond from α-keto ester 
3g) instead of carbonyl group. 
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Although chiral metal phosphates catalyzed 1,4-addition to such substrate is known,5 the 
asymmetric Michael addition using silyl ketene acetals has not been reported. We anticipated 
that our catalytic system might enable enolsilanes to act as nucleophiles to attack the double 
bond in an asymmetric Mukaiyama-Michael addition process. 
We started our investigation by employing 1-(tert-Butyldimethylsilyloxy)-1-methoxyethene 
8 as the nucleophile to react with 3g in the presence of the racemic catalyst Mg[P17]2 (Scheme 
3.4). 
 
Scheme 3.4 Mukaiyama-Michael reaction of 3g with 8 
As shown in Scheme 3.4, when Michael acceptor 3g and silyl ketene acetal 8 were added at 
one to one ratio into the solution of MS and catalyst at room temperature, they reacted 
completely via the addition intermediate and two products 9 and 10 were obtained and identified 
by NMR. And the ratio of product 9 and 10 was nearly one to one, according to NMR spectra. In 
COOEt
O
+
TBSO
OMe
O
MeO
CO2Et
O
Mg[P17]2, 4Å MS, DCM
Ph
O
COOEt
MeO
O
TBS
Ph
O
COOEt
MeO
O
TBS
+
Ph
O
COOEt
OTBSMeO
Methods
+
Ph
O
COOEt
OHMeO
Methods:  12N HCl/THF 15 : 1
TFA/THF/DCM 1 : 3
2N HCl/THF, 0°C to rt, 2h 25 : 1
Ph CO2Et
O
MeO OH
by product 13
3g 8
9 10
11 12
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order to remove the TBS protecting group, several methods were performed. 9 can convert to the 
addition product 11 and the cyclic product 12 by removing the TBS group, because 11 and 12 are 
interchangeable when acid applied. And 10 can also yield 11 and 12. So by applying different 
conditions, different ratios of 11 and 12 could be observed. This could be a good opportunity to 
enrich one of the final products and form one (major) product in one port, which simplifies the 
purification and determination of the product and makes the asymmetric transformation more 
useful. When using concentrated HCl in THF at room temperature to remove the TBS group, 11 
and 12 were obtain with a ratio of 15:1. And TFA in THF and DCM solvents mixture favored the 
cyclic product 12 (Scheme 3.4). The optimal condition for removing the TBS group was found to 
be 2N hydrochloric acid in THF and the temperature was controlled to warm from 0°C to room 
temperature in 2 hours. It is worthy noting that there was less than 8% of the 1,2-addition 
product 13 isolated as the by-product, which showed the attacking to carbonyl also exist. 
After finding out the best condition for deprotection procedure, a catalyst survey was 
performed to determine the optimal catalyst (Table 3.1). The yield was isolated of product 11 
and the ee was also the test result of 11. Both Mg and Ca chiral phosphates were prepared and 
applied in the reaction between 1-(tert-Butyldimethylsilyloxy)-1-methoxyethene 8 and 3g, since 
they both showed reactivity for the previous HDA reaction. The catalysts with sterically hindered 
phosphates P1, P2 and P3 showed moderate reactivity, with low ee observed in long reaction 
time (Table 3.1, entries 1-5). 
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Table 3.1 Catalyst survey of asymmetric Mukaiyama-Michael reaction 
 
Only Mg[P3]2 gave 95% yield and 56% ee in 1.5h (entry 6). The low yield was the 
consequence of the coexisting Mukaiyama-Aldol reaction, which was the 1,2-addition to 
carbonyl instead of conjugated addition to double bond (Scheme 3.4). Comparing to the result of 
less hindered racemic catalyst Mg[P17]2, different catalysts or different hindrance could affect, if 
not alter, the chemoselectivity, although they were the same type of catalyst. 
With different steric hindrance of phosphates, magnesium phosphate Mg[P4]2 was found to 
provide the Mukaiyama-Michael product 11 with modest enantioselectivity but good yield in 
only 5 minutes (Table 3.1, entry 8), which showed tuning the steric substituents of 3,3’-position 
affected the catalytic reactivity dramatically. The calcium version Ca[P4]2 (entry 7) also gave 
COOEt
O
+
TBSO
OMe
O
MeO
CO2Et
O1) catalyst, 4Å MS, DCM
2) 2N HCl/THF
entry M[P]2 time yield (%)[a] ee (%)[b]
1 24 h 71 10
2
O
O P(R)
R
R
P1: R= 9-anthryl
P2: R= 9-phenylanthryl
P3: R= SiPh3
P4: R= 2,4,6-(iPr)3-C6H2
P5: R= 2-naphthyl
P6: R= 1-naphthyl
P8: VAPOL
P18: R= 2,6-(iPr)2-4-AdC6H2
P19: R= 2,6-(iPr)2-4-tBuC6H2
O
O
2
M
Ca[P1]2
Mg[P1]2 24 h 62 24
3 Ca[P2]2 48 h 74 35
4 Mg[P2]2 24 h 84 25
5 Ca[P3]2 48 h 81 18
6 Mg[P3]2 1.5 h 95 56
7 Ca[P4]2 1 h 92 10
8 Mg[P4]2 5 min 83 50
9 Ca[P5]2 10 min 93 -3
10 Mg[P5]2 5 min 93 9
11 Ca[P6]2 5 min 94 46
12 Mg[P6]2 5 min 94 66
[a] Reaction conditions: 3g (1.0 equiv.), 8 (1.1 equiv.), 2.5 mol% 
catalyst, in DCM (0.05 M) with 4Å MS 20 mg/mL. Isolated yield. 
[b] Determined by chiral HPLC analysis.
3g 8 11
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better reactivity than the other calcium ones, but not as good as Mg[P4]2. Further investigation 
revealed magnesium 1-naphthyl-BINOL phosphate Mg[P6]2, the same phosphate that showed 
excellent enantioselectivity, promoted the transformation with excellent yield and 66% ee, and 
nearly no 1,2-addition product was isolated (entry 12). Much lower enantioselectivities were 
obtained when similar 2-naphthyl-BINOL phosphate was used (entries 9 and 10). 
Table 3.2 Catalyst survey of asymmetric Mukaiyama-Michael reaction, continued 
 
With respect to further improve the enantioselectivity, more chiral magnesium and calcium 
phosphates were employed to the reaction (Table 3.2). Mg VAPOL-phosphate yield 93% product 
in 10 mins with low ee, and Ca VAPOL-phosphate was less reactive than Mg catalyst (Table 3.2, 
entries 1 and 2). Comparing Mg phosphates results with Ca phosphates results from Table 3.1, 
COOEt
O
+
TBSO
OMe
O
MeO
CO2Et
O1) catalyst, 4Å MS, DCM
2) 2N HCl/THF
entry M[P]2 time yield (%)[a] ee (%)[b]
1 24 h 90 33
2
O
O P(R)
R
R
P8: VAPOL
P18: R= 2,6-(iPr)2-4-AdC6H2
P19: R= 2,6-(iPr)2-4-tBuC6H2
O
O
2
M
Ca[P8]2
Mg[P8]2 10 min 93 -17
3 Mg[P14]2 10 min 96 24
4 Mg[P15]2 5 min 72 79
5 Mg[P18]2 5 min 91 74
6 Mg[P19]2 4 h 76 18
7 Mg[P20]2 24 h 87 76
8 Mg[P21]2 10 min 96 4
[a] Reaction conditions: 3g (1.0 equiv.), 8 (1.1 equiv.), 2.5 mol% 
catalyst, in DCM (0.05 M) with 4Å MS 20 mg/mL. Isolated yield. 
[b] Determined by chiral HPLC analysis.
3g 8 11
O
O P(R)
R
R
P14:R= 1-naphthyl
P15:R= 2,4,6-(iPr)3C6H2
P20:R= 9-phenylanthryl
P21:R= SiPh3
O
O
2
M
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Mg phosphates showed to be better catalysts for the asymmetric Mukaiyama-Michael addition, 
in respect of reaction time, yield and ee. Interestingly, Ca catalysts were proven to be the optimal 
catalysts for the HDA reaction from last chapter, the Mg ones performed better in the addition 
reaction. Although the same activation mode and transition state was proposed, the slight 
differences between two medals, such as atom radius, electronegativity, and oxophilicity affected 
their activities as catalysts. One cannot tell which one of those two metals is optimal for certain 
transformation unless both are tried. 
The preliminary results showed the chiral magnesium phosphates were superior catalysts for 
the addition reaction; so next only magnesium catalysts were synthesized and applied. The 
encouraging result came from applying Mg[P18]2, the sterically hindered adamantyl-modified 
TRIP catalyst, in terms of reactivity and enantioselectivity (Table 3.2, entry 5). The less hindered 
t-Butyl-modified one Mg[P19]2, however, gave disappointing result (entry 6), although their 
structural differences were considered to be insignificant. The different results (50% ee for 
Mg[P4]2 vs 74% ee for Mg[P18]2 vs 18% ee for Mg[P19]2) showed the discreteness of 
selectivity from catalysts with resembling structures. 
The H8-BINOL variant catalysts were also screened (entries 3, 4, 7 and 8 from Table 3.2). 
H8-Trip catalyst Mg[P15]2 and 9-phenylanthryl-H8-BINOL phosphate Mg[P20]2 both afforded 
the products with good yield and decent enantioselectivity (entries 4 and 7). 
At this stage, four chiral magnesium phosphates Mg[P6]2, Mg[P15]2, Mg[P18]2 and 
Mg[P20]2 showed improvable results, with 66%, 79%, 74% and 76% ee respectively. Altering 
the substrate was needed to further improve the selectivity. By doing this, the energy of 
transition state could be slightly altered because of the different positioning of the functional 
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groups. The tiny amount of energy difference for enantiomeric discrimination could become 
bigger to favor one enantiomeric pure product more. Methyl ester 14a instead of ethyl ester 3g 
was employed, and all the four catalyst candidates were tested (Table 3.3). 
Table 3.3 Asymmetric Mukaiyama-Michael reaction of methyl ester 
 
All of the four magnesium phosphates displayed better reactivity towards the methyl ester at 
room temperature. Mg[P18]2 exhibited to be more superior (entry 3) in respect of both yield and 
ee, and was chosen to be carried on to solvent screening. 
To further improve the enantioselectivity, more solvents were tested at room temperature 
(Table 3.4). Chlorinated solvents were suitable for this transformation with respect to the yield 
(entries 1, 4 and 6), but ee slightly lost with the increase of molecular weight. Aromatic solvents, 
such as toluene and benzene gave good enantioselectivity with better yield (entries 2 and 5). 
COOMe
O
+
TBSO
OMe
O
MeO
COOMe
O1) catalyst, 4Å MS, DCM
2) 2N HCl/THF
entry M[P]2 time yield (%)[a] ee (%)[b]
1 2 min 96 70
2
O
O P(R)
R
R
P6: R= 1-naphthyl
P18: R= 2,6-(iPr)2-4-AdC6H2
O
O
2
M
Mg[P6]2
Mg[P15]2 5 min 62 78
3 Mg[P18]2 2 min 86 87
4 Mg[P20]2 3 h 95 80
[a] Reaction conditions: 14a (1.0 equiv.), 8 (1.1 equiv.), 2.5 mol% 
catalyst, in DCM (0.05 M) with 4Å MS 20 mg/mL. Isolated yield. 
[b] Determined by chiral HPLC analysis.
14a 8 15a
O
O P(R)
R
R
P15:R= 2,4,6-(iPr)3C6H2
P20:R= 9-phenylanthryl
O
O
2
M
 67 
When diethyl ether was employed, lower ee and longer reaction time was observed, although 
yield of 15a was excellent. The catalytic reactivity was interfered by the ether solvent. The best 
enantioselectivity was obtained when cyclohexane was used (entry 7), 95% ee was obtained 
alone with 95% yield, and no 1,2-addition product was found. When 1-methoxy-1-
trimethylsiloxyethene was employed instead of 1-(tert-Butyldimethylsilyloxy)-1-methoxyethene 
8, Michael acceptor 14a was consumed faster but lower yield and ee were afforded (entry 8). 
Moreover, substantial amount of 1,2-addition by-product was observed when 1-methoxy-1-
trimethylsiloxyethene was used. This showed sterically hindrance of the silylketene acetal 
substrate was crucial for reaching not only high-level stereoselectivity but also the 
chemoselectivity. The optimal reaction condition was found to be using Mg[P18]2 as catalyst, 
cyclohexane as solvent, with the presence of 4Å MS and at room temperature. 
Table 3.4 Solvent survey of asymmetric Mukaiyama-Michael reaction 
 
COOMe
O
+
TBSO
OMe
O
MeO
COOMe
O1)Mg[P18]2, 4Å MS, solvent, rt
2) 2N HCl/THF
O
O P(R)
R
R
Mg[P18]2
O
O
2
Mg
14a 8 15a
R:
entry solvent time yield (%)[a] ee (%)[b]
1 2 min 86 87
2
DCM
Toluene 15 min 92 87
3 ether 2 h 95 64
4 DCE 5 min 91 86
5 Benzene 10 min 95 87
6 2 h 94 71
7 Cyclohexane 2 min 95 95
8[c] Cyclohexane 52 87
[a] Reaction conditions: 14a (1.0 equiv.), 8 (1.1 equiv.), 2.5 
mol% Mg[P18]2, in solvent (0.05 M) with 4Å MS 20 mg/mL. 
Isolated yield. [b] ee determined by HPLC analysis on chiral 
stationary phases.[c] Using 1-methoxy-1-trimethylsiloxyethene 
as substrate.
CHCl3
2 min
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Owing to their synthetic interest, the scope of this asymmetric transformation was further 
examined by applying the optimized condition towards the forming optically active 1,5-
dicarbonyl compounds (Table 3.5). 
Table 3.5 Substrate scope for asymmetric Mukaiyama-Michael reaction 
 
Heteroaromatic rings like furan and thiophene (14b, 14c) worked as well as the phenyl ring 
(14a), the potential coordination of the product to the catalyst did not interfere the catalytic 
+
1) Mg[P18]2 (2.5 mol%), rt, 
4Å MS, Cyclehexane, 1h
2) 2N HCl/THF
14a-o 8 15a-o
entry 14 yield (%)[a] ee (%)[b]
1 14a 95 95
2 2-furyl 14b 91 95
3 2-thienyl 14c 97 95
4[c] 95 92
5 92 96
6 92 98
R CO2Me
O TBSO
OMe R
O
MeO
CO2Me
O
R
2-naphthyl 14d
4-FC6H4 14e
4-ClC6H4 14f
7 4-BrC6H4 14g 92 96
8 4-MeOC6H4 14h 98 94
9[d] 4-CF3C6H4 14i 91 96
10[d] 4-NO2C6H4 14j 95 95
11[d] 4-CNC6H4 14k 95 99
12[d] 4-CHOC6H4 14l 97 98
13[d] 3-ClC6H4 14m 93 98
14[d] 3-BrC6H4 14n 92 99
15[d] PhCH=CH 14o 93 94
Ph
[a] Reaction conditions: 14 (1.0 equiv.), 8 (1.1 equiv.), 2.5 mol% Mg[P18]2, in 
cyclohexane (0.05 M) with 4Å MS 20 mg/mL. Isolated yield. [b] ee determined 
by HPLC analysis on chiral stationary phases. [c] Reaction time: 2 hours. [d] 
Reaction was performed at 10 °C.
 69 
activity. The sterically hindered 2-naphthyl aromatic ring (14d) performed well in this condition, 
92% ee was observed, although double reaction time was required. Broad functional groups on 
the aromatic moieties, such as halides, methoxy, nitro, trifluoromethyl and cyano groups were 
well tolerated under the reaction conditions, regardless of their steric and electronic property, 
affording 1,5-dicarbonyl products in good yields and enantioselectivities (14e-14k), although 
lower temperature was required in some cases (14i-14k). When the formyl group was present in 
the phenyl ring (14l), the reaction still went through the Mukaiyama-Michael pathway with 98% 
ee and 97% yield. The carbonyl group on phenyl ring (such as benzaldehyde) is known to go 
through Aldol reaction with enol silanes in the presence of Lewis acids, but in this case, great 
chemoselectivity displayed and the double bond in 14l was more reactive towards the 
nucleophilic attack due to the chelation to the catalyst of adjacent 1,2-dicarbonyl group. The 
halides in meta- instead of para-position of aromatic ring (14m and 14n) also yielded the 
products with excellent ees, when low temperature was provided. In addition, diene substrate 
14o, which contained two conjugated double bonds, was also suitable for the same conditions. 
The β,γ-double bond was targeted specifically to react with 7, yielding the 1,5-dicarbonyl not 
1,7-dicarbonyl product with high ee. This showed the good regioselectivity of this 
transformation. 
3.4 Conclusion 
In this chapter, highly catalytic asymmetric Mukaiyama-Michael addition of silyketene acetal 
to β,γ-unsaturated α-keto esters was disclosed. The design of this transformation was based on 
the unique carbonyl activation discovered in chapter 2. Distinct from the HDA reaction of the 
carbonyl from 1,2-dicarbonyl compound, this Michael addition reacted chemoselectively with 
conjugated double bond in the presence of 1,2-dicarbonyl group, which chelated with the 
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catalysts. Both magnesium and calcium chiral phosphates showed the catalytic reactivity in 
terms of chemoselectivity as well as enantioselectivity. And the optimal catalyst was found to be 
sterically hindered adamantyl-modified TRIP Mg[P18]2. With the help of molecular sieves and 
cyclohexane as solvent, several functionalized 1,5-dicarbonyl products with varying substituents 
at aryl group were obtained in excellent yields and excellent enantioselectivity. In several 
substrates, the catalytic system also demonstrated great chemoselectivity and regioselectivity. 
The transition state for the Michael addition was proposed to be similar to the one proposed 
for the HDA reaction, because their substrates shared the same structural motif 1,2-dicarbonyl 
group. 
The discovered enantioselective Mukaiyama-Michael addition is important complementary 
to the carbonyl activation by chiral alkaline earth metal phosphate. Together with the asymmetric 
HDA reaction, chiral phosphate chemistry was established to be a robust and versatile type of 
catalyst and had numerous potential applications on enantioselective transformation. 
3.5 Future direction 
In the past decade, the chiral phosphoric acid chemistry and chiral metal phosphate chemistry 
have been intensively developed as privileged catalysts and showed application for valuable 
organic transformations. The substrates that phosphoric acid and phosphate could activate are 
shifting from imines to variety of other functional groups. 
During this work, the activation of hydroxyl by phosphoric acid was discovered. The active 
intermediate was formed between phosphoric acid and conjugated iminium ion. This ion pair 
intermediate could be applied on many other reactions, such as Michael addition, Diels-Alder 
reaction, ene reaction, Friedel-Crafts reaction, transfer hydrogenation as well as many others. 
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Since the chiral ion pair was also vital for enantioselectivity, and it was proved to be effective, 
high enantioselectivity should be expected to reach with right substrates and optimized reaction 
conditions. 
The robust catalytic system using chiral alkaline metal phosphate reported in chapter 2 and 3 
was still at its early research state. Further expansion of the reaction scope and utility of those 
products need to be done to find the limitation of those transformations. Although the catalyst 
loading was considered to be low in the field of organocatalysis, 1 mol% was still high 
comparing to organometallic chemistry. Noticing the reactivity was high and the reaction usually 
finished in less an hour, further lowing the catalyst loading is possible, through tuning the 
reaction temperature and concentration and slowing addition. 
And more work need to be done on more detailed mechanistic studies. In situ NMR could be 
used to observe the chelation between the substrate and catalyst. Non-linear effect experiments 
could be performed to confirm the active catalyst to be one Ca with two phosphates. If the 
chelation crystal of substrate and catalyst could be grown and examined by X-ray structure 
analysis, it will provide the direct evidence of the intermediate and give more insight to the 
transition state and the outcome of absolute stereochemistry. 
The novel activation of carbonyl group could lead to develop asymmetric reactions, such as 
Aldol reaction, ene reaction, acetal formation, reduction. And success of activation of conjugated 
double bond could potentially be used in reactions where double bond acted as electrophile to 
give chiral products, such as hydrogenation, Diels-Alder reaction, Friedel-Crafts reaction, 
organometallic reagent addition, as well as transition metal catalyzed reactions. 
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Chapter 4 Experimental Procedures 
4.1 Experimental procedures for Chapter 1 
4.1.1 General consideration 
All reactions were carried out in flame-dried screw-cap test tubes fitted with a septum and 
performed under an atmosphere of dry argon with magnetic stirring, unless otherwise noted. 
Molecular Sieves (4Å powdered) were activated by flame under high vacuum and stored at 180 
°C. THF was purified by passing the degassed solvent through a column of activated alumina 
prior to use in reactions. Commercial grade reagents and solvents were used without further 
purification. Chiral BINOL was purchased from commercial sources and used without further 
purification. All starting materials were purchased from Aldrich and TCI and used without 
further purification. Thin-layer chromatography (TLC) analysis of reaction mixtures was 
performed using Merck silica gel 60 F254 plates. Flash column chromatography was carried out 
on Merck 60 silica gel (230-400 mesh). Enantiomeric excess (ee) was determined using a Varian 
Prostar HPLC with a 210 binary pump and a 335 diode-array detector. Column conditions are 
reported in the experimental section below. Optical rotations were performed on a Rudolph 
Research Analytical Autopol IV polarimeter (λ 589) using a 700-µL cell with a path length of 1-
dm. 1H, 13C and 31P NMR spectra were recorded on a Varian Inova 400 Spectrometer (400 MHz 
for 1H, 100 MHz for 13C, and 162 MHz for 31P). 1H and 13C chemical shifts are reported in ppm 
downfield from tetramethylsilane (TMS). 31P spectra are reported in ppm downfield of 85% 
aqueous phosphoric acid. The following abbreviations were used to designate chemical shift 
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multiplicities: s=singlet, d=doublet, t=triplet, q=quartet, m=multiplet. High Resolution Mass 
HRMS data were measured on an Agilent 6210 LC/MS ESI/TOF mass spectrometer with 
electrospray ionization. Compounds described in the literature were characterized by comparing 
their 1H NMR, and 13C NMR to the reported values. 
4.1.2 General procedure for the preparation of substrates 1 
 
To a solution of 16 (10.0 mmol) in MeOH (60 mL) was added NaBH4 (5 mmol) at 0 °C. The 
reaction mixture was stirred for 15 min at 0 °C and an additional 30 min at room temperature. An 
additional portion of NaBH4 (5 mmol) was added at room temperature and the resulting solution 
was stirred for 1 h. Saturated aqueous NH4Cl was added, and the mixture was extracted 3x with 
DCM. The organic phase was separated and washed with water, followed by brine, dried over 
anhydrous Na2SO4 and concentrated in vacuo. Purification of the crude product by column 
chromatography on silica gel (Hexanes/EtOAc, 3:1) afforded the reduction product. The reduced 
product (1 mmol) was dissolved in anhydrous THF (15 mL) and the aryl magnesium bromide 
solution (3.7 eq) was added at 0 °C. The reaction was stirred for 30 min at 0 °C and then 15 h at 
room temperature. Saturated aqueous NH4Cl was added, and the mixture was extracted 3x with 
EtOAc. The organic phase was washed with water, followed by brine, dried over Na2SO4 and 
concentrated in vacuo. The crude product was purified by column chromatography on silica gel 
(Hexanes/EtOAc, 4:1) to give the title product. 
N
R3
O O
OMe
R1
1) NaBH4, MeOH
2) R2MgBr, THF N
R3
O
R1
R2
OH
R2
116
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4.1.3 Procedure for the preparation of catalyst P14 
 
(R)-H8-BINOL 17 (0.186 g, 0.34 mmol) was dissolved in pyridine (5 mL) under an argon 
atmosphere in a flame-dried round-bottom flask (25 mL). To the resulting solution was added 
phosphorus oxychloride (0.261 g, 1.7 mmol, 5.0 equiv) at room temperature and the reaction 
mixture was stirred at 65 °C for 15 h. After cooling to room temperature, water (2 mL) was 
added and the resulting suspension was stirred at 65 °C for an additional 6 h. Dichloromethane 
was added to the cooled reaction mixture and pyridine was removed by reverse extraction with 
aqueous HCl (6M). The organic phase was dried over anhydrous Na2SO4, and concentrated in 
vacuo. Purification of the crude product by column chromatography on silica gel (eluent: 5% 
MeOH in DCM) provided a white solid. The product was dissolved in 10 mL DCM and 10 mL 
aqueous 6M HCl was added. The solution was stirred for 3 h. The organic phase was separated, 
dried over anhydrous Na2SO4, and then concentrated to afford chiral phosphoric acid P14 (0.166 
g, 80% yield). 1H NMR (400 MHz, DMSO-d6): δ 8.05-7.92 (m, 4H), 7.62-7.42 (m, 10H), 7.18 (s, 
2H), 3.03-2.82 (m, 6H), 2.55 (s, 2H), 2.01-1.83 (m, 6H).  13C NMR (100 MHz, DMSO-d6): δ 
144.02, 143.93, 136.96, 136.65, 135.13, 134.48, 133.74, 133.61, 132.79, 132.24, 131.85, 131.61, 
131.35, 129.70, 128.12, 127.98, 127.83, 127.69, 127.49, 126.77, 126.35, 126.18, 125.63, 125.43, 
O
O P OH
OOH
OH
P1417
1) POCl3, pyridine
2) H2O, HCl
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124.93, 28.57, 27.51, 22.23, 22.21. 31P NMR (162 MHz, DMSO-d6) δ -1.99. [a]25D = -216.12° (c 
=0.245, CHCl3).  HRMS (ESI) Calcd for C40H33O4P ([M]+) 608.21110, Found 608.21165. 
4.1.4 General procedure for asymmetric Pinacol rearrangement 
To a flame-dried reaction tube, charged with 30 mg 4Å MS powder, was added 2-(1-methyl-
1H-indol-3-yl)-1,1-diphenylethane-1,2-diol 1 (0.10 mmol, 34.3 mg), catalyst P14 (0.0025mmol, 
1.5 mg) and benzene (2.0 mL). The resulting solution was stirred at room temperature for the 
indicated time. The crude product was purified directly by flash column chromatography on 
silica gel (Hexanes/EtOAc = 10/1 to 5/1) to afford product 2. Enantiomeric excess was 
determined by chiral HPLC analysis. 
 
2-(1-benzyl-1H-indol-3-yl)-1,2-diphenylethanone (2a): 84% yield, 95% ee. Enantiomeric 
excess was determined by chiral HPLC analysis (Chiralcel OD-H column, 1.0 mL/min, 93:7 
hexanes/iPrOH): tR(major) = 16.07 min, tR(minor) = 14.59 min. 14.59 min. [a]23D = -227.69° (c = 
0.470, THF).  1H NMR (400 MHz, Acetone-d6): δ 8.15 (d, J = 7.2 Hz, 1H), 7.65-7.53 (m, 2H), 
7.51-7.43 (m, 4H), 7.37-7.18 (m, 8H), 7.13-6.98 (m, 5H), 6.55 (s, 1H), 5.42 (s, 2H).  13C NMR 
(100 MHz, Acetone-d6): δ  199.540, 141.676, 140.234, 139.055, 138.734, 134.689, 131.138, 
130.921, 130.572, 130.452, 130.372, 130.041, 129.486, 129.148, 128.620, 128.524, 123.683, 
121.119, 121.005, 115.351, 111.992, 52.068, 51.340. HRMS (ESI) Calcd for C29H24NO 
([M+H]+) 402.18524, Found 402.18462. 
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2-(1-methyl-1H-indol-3-yl)-1,2-diphenylethanone (2b): 94% yield, 96% ee. Enantiomeric 
excess was determined by chiral HPLC analysis (Chiralcel AD-H column, 1.0 mL/min, 90:10 
hexanes/iPrOH): tR(major) = 13.47 min, tR(minor) = 14.60 min. [a]23D = -284.55° (c = 0.505, 
THF).  1H NMR (400 MHz, Acetone-d6): δ 8.18-8.08 (m, 2H), 7.63-7.50 (m, 2H), 7.50-7.38 (m, 
3H), 7.35 (d, J = 8.2 Hz, 1H), 7.29 (t, J = 7.6 Hz, 2H), 7.23-7.12 (m, 2H), 7.10 (s, 1H), 7.04 (t, J 
= 7.6 Hz, 2H), 6.52 (s, 1H), 3.78 (s, 3H).  13C NMR (100 MHz, Acetone-d6): δ  199.494, 
141.823, 139.233, 139.050, 134.702, 131.093, 130.832, 130.551, 130.474, 130.252, 130.015, 
129.118, 128.483, 123.482, 120.776, 114.621, 111.355, 51.880, 33.831. HRMS (ESI) Calcd for 
C23H20NO ([M+H]+) 326.15394, Found 326.15348. 
 
2-(1-allyl-1H-indol-3-yl)-1,2-diphenylethanone (2c): 84% yield, 95% ee. Enantiomeric 
excess was determined by chiral HPLC analysis (Chiralcel AD-H column, 1.0 mL/min, 90:10 
hexanes/iPrOH): tR(major) = 11.41 min, tR(minor) = 14.77 min. [a]23D = -244.33° (c = 0.475, 
THF).  1H NMR (400 MHz, Acetone-d6): δ 8.12 (d, J = 7.2 Hz, 1H), 7.64-7.51 (m, 2H), 7.50-
7.42 (m, 4H), 7.36 (d, J = 8.4 Hz, 1H), 7.29 (t, J = 7.6 Hz, 2H), 7.23-7.17 (m, 2H), 7.16-7.11 (m, 
2H), 7.01 (t, J = 7.2 Hz, 1H), 6.53 (s, 1H), 6.06-5.92 (m, 1H), 5.09 (dd, J = 10.4, 1.6 Hz, 1H), 
4.99 (dd, J = 17.2, 1.6 Hz, 1H), 4.78 (d, J = 5.2 Hz, 2H).  13C NMR (100 MHz, Acetone-d6): δ 
N
Ph O
Ph
N
Allyl
Ph O
Ph
 78 
 199.523, 141.701, 139.015, 138.606, 136.140, 134.697, 131.075, 130.537, 130.449, 130.033, 
129.355, 129.293, 128.507, 123.540, 120.990, 120.910, 117.899, 115.090, 111.794, 51.928, 
50.115. HRMS (ESI) Calcd for C25H22NO ([M+H]+) 352.16959, Found 352.16924. 
 
1,2-bis(4-fluorophenyl)-2-(1-methyl-1H-indol-3-yl)ethanone (2d): 90% yield, 94% ee. 
Enantiomeric excess was determined by chiral HPLC analysis (Chiralcel AD-H column, 1.0 
mL/min, 90:10 hexanes/iPrOH): tR(major) = 13.91 min, tR(minor) = 11.80 min. [a]23D = -307.85° 
(c = 0.455, THF).  1H NMR (400 MHz, Acetone-d6): δ 8.24-8.19 (m, 2H), 7.59 (d, J = 8.0 Hz, 
1H), 7.50-7.44 (m, 2H), 7.37 (d, J = 8.4 Hz, 1H), 7.26-7.14 (m, 3H), 7.11 (s, 1H), 7.08-6.99 (m, 
3H), 6.53 (s, 1H), 3.79 (s, 3H).  13C NMR (100 MHz, Acetone-d6): δ 197.971, 168.609, 166.098, 
164.855, 162.441, 139.290, 137.781, 135.402, 133.536, 133.444, 132.926, 132.846, 130.203, 
128.883, 123.644, 120.989, 120.704, 117.484, 117.265, 116.663, 116.450, 114.231, 111.466, 
51.043, 33.871.  19F NMR (400 MHz, Acetone-d6): δ  -108.067, -108.088, -108.103, -108.118, -
108.139, -118.431, -118.455, -118.468, -118.481, -118.505. HRMS (ESI) Calcd for C23H18F2NO 
([M+H]+) 362.13510, Found 362.13405. 
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1,2-bis(4-chlorophenyl)-2-(1-methyl-1H-indol-3-yl)ethanone (2e): 99% yield, 93% ee. 
Enantiomeric excess was determined by chiral HPLC analysis (Chiralcel OD-H column, 1.0 
mL/min, 90:10 hexanes/iPrOH): tR(major) = 21.92 min, tR(minor) = 10.27 min. [a]23D = -268.58° 
(c = 0.425, THF).  1H NMR (400 MHz, Acetone-d6): δ 8.12 (d, J = 8.8 Hz, 2H), 7.58 (d, J = 8.0 
Hz, 1H), 7.49 (d, J = 8.4 Hz, 2H), 7.44 (d, J = 8.4 Hz, 2H), 7.37 (d, J = 8.4 Hz, 1H), 7.31 (d, J = 
8.4 Hz, 2H), 7.17 (t, J = 7.6 Hz, 1H), 7.12 (s, 1H), 7.03 (t, J = 7.2 Hz, 1H), 6.53 (s, 1H), 3.79 (s, 
3H).  13C NMR (100 MHz, Acetone-d6): δ 198.138, 140.590, 140.523, 139.298, 137.350, 
133.958, 132.847, 132.360, 130.661, 130.307, 129.965, 128.807, 123.704, 121.065, 120.671, 
113.671, 111.511, 51.304, 33.895. HRMS (ESI) Calcd for C23H18Cl2NO ([M+H]+) 394.07600, 
Found 394.07621. 
 
2-(1-methyl-1H-indol-3-yl)-1,2-dip-tolylethanone (2f): 99% yield, 96% ee. Enantiomeric 
excess was determined by chiral HPLC analysis (Chiralcel OD-H column, 1.0 mL/min, 90:10 
hexanes/iPrOH): tR(major) = 16.32 min, tR(minor) = 7.39 min. [a]23D = -212.82° (c = 0.500, 
THF).  1H NMR (400 MHz, Acetone-d6): δ 8.04 (d, J = 8.0 Hz, 2H), 7.56 (d, J = 8.0 Hz, 1H), 
7.35-7.32 (m, 3H), 7.26 (d, J = 8.0 Hz, 2H), 7.15 (t, J = 7.4 Hz, 1H), 7.09 (d, J = 8.0 Hz, 2H), 
7.05 (s, 1H), 7.00 (t, J = 7.4 Hz, 1H), 6.42 (s, 1H), 3.76 (s, 3H), 2.35 (s, 3H), 2.26 (s, 3H).  13C 
NMR (400 MHz, Acetone-d6): δ 199.178, 145.383, 139.187, 138.898, 137.832, 136.563, 
131.052, 130.939, 130.683, 130.173, 129.182, 123.380, 120.814, 120.693, 115.097, 111.275, 
N
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51.392, 33.794, 22.469, 22.010. HRMS (ESI) Calcd for C25H24NO ([M+H]+) 354.18524, Found 
354.18624. 
 
1,2-bis(4-methoxyphenyl)-2-(1-methyl-1H-indol-3-yl)ethanone (2g): 97% yield, 91% ee. 
Enantiomeric excess was determined by chiral HPLC analysis (Chiralcel OD-H column, 1.0 
mL/min, 90:10 hexanes/iPrOH): tR(major) = 51.88 min, tR(minor) = 19.57 min. [a]23D = -226.30° 
(c = 0.460, THF).  1H NMR (400 MHz, Acetone-d6): δ 8.13 (d, J = 8.8 Hz, 2H), 7.55 (d, J = 8.0 
Hz, 1H), 7.40-7.29 (m, 3H), 7.15 (t, J = 7.6 Hz, 1H), 7.04 (s, 1H), 7.00 (d, J = 7.6 Hz, 1H), 6.97 
(d, J = 8.8 Hz, 2H), 6.84 (d, J = 8.8 Hz, 2H), 6.38 (s, 1H), 3.84 (s, 3H), 3.77 (s, 3H), 3.73 (s, 3H).  
13C NMR (100 MHz, Acetone-d6): δ 198.211, 165.318, 160.479, 139.181, 133.964, 132.821, 
131.995, 131.828, 130.068, 129.178, 123.346, 120.833, 120.648, 115.588, 115.391, 111.253, 
56.881, 56.419, 50.636, 33.789. HRMS (ESI) Calcd for C25H24NO3 ([M+H]+) 386.17507, Found 
386.17454. 
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1,2-bis(3,5-dimethylphenyl)-2-(1-methyl-1H-indol-3-yl)ethanone (2h): 94% yield, 93% 
ee. Enantiomeric excess was determined by chiral HPLC analysis (Chiralcel OD-H column, 1.0 
mL/min, 90:10 hexanes/iPrOH): tR(major) = 8.88 min, tR(minor) = 6.13 min. [a]23D = -197.17° (c 
= 0.480, THF).  1H NMR (400 MHz, Acetone-d6): δ 7.79 (s, 2H), 7.57 (d, J = 7.6 Hz, 1H), 7.34 
(d, J = 8.0 Hz, 1H), 7.20 (s, 1H), 7.15 (t, J = 7.6 Hz, 1H), 7.09 (s, 2H), 7.06 (s, 1H), 7.00 (t, J = 
7.6 Hz, 1H), 6.84 (s, 1H), 6.41 (s, 1H), 3.77 (s, 3H), 2.31 (s, 6H), 2.22 (s, 6H).  13C NMR (100 
MHz, Acetone-d6): δ 199.780, 141.705, 139.999, 139.323, 139.245, 139.153, 136.143, 130.283, 
130.030, 129.253, 128.783, 128.306, 123.341, 120.794, 120.648, 114.927, 111.270, 51.597, 
33.805, 22.361, 22.215. HRMS (ESI) Calcd for C27H28NO ([M+H]+) 382.21654, Found 
382.21765. 
 
2-(1-methyl-1H-indol-3-yl)-1,2-di(naphthalen-2-yl)ethanone (2i): 93% yield, 93% ee. 
Enantiomeric excess was determined by chiral HPLC analysis (Chiralcel OD-H column, 1.0 
mL/min, 90:10 hexanes/iPrOH): tR(major) = 30.73 min, tR(minor) = 13.75 min. [a]23D = -291.86° 
(c = 0.535, THF).  1H NMR (400 MHz, Acetone-d6): δ 8.94 (s, 1H), 8.19 (dd, J = 6.8, 1.20 Hz, 
1H), 8.05-8.01 (m, 2H), 7.94 (d, J = 6.8 Hz, 1H), 7.91 (d, J = 6.4 Hz, 1H), 7.85-7.79 (m, 3H), 
7.72-7.67 (m, 2H), 7.62-7.58 (m, 1H), 7.57-7.53 (m, 1H), 7.44-7.41 (m, 2H), 7.35 (d, J = 6.8 Hz, 
1H), 7.22-7.19 (m, 1H), 7.18-7.14 (m, 1H), 7.04-7.00 (m, 1H), 6.91 (s, 1H), 3.76 (s, 3H). 13C 
NMR (100 MHz, Acetone-d6): δ 199.624, 139.540, 139.203, 137.320, 136.254, 135.371, 
134.512, 134.412, 132.205, 131.427, 130.473, 130.328, 130.196, 129.590, 129.557, 129.514, 
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129.472, 129.336, 129.145, 128.625, 127.756, 127.463, 126.349, 123.484, 120.844, 114.500, 
111.373, 52.031, 33.799. HRMS (ESI) Calcd for C31H24NO ([M+H]+) 426.18524, Found 
426.18690. 
 
2-(5-fluoro-1-methyl-1H-indol-3-yl)-1,2-diphenylethanone (2j): 95% yield, 96% ee. 
Enantiomeric excess was determined by chiral HPLC analysis (Chiralcel AD-H column, 1.0 
mL/min, 90:10 hexanes/iPrOH): tR(major) = 15.25 min, tR(minor) = 18.15 min. [a]23D = -227.26° 
(c = 0.530, THF).  1H NMR (400 MHz, Acetone-d6): δ 8.17 (d, J = 7.2 Hz, 2H), 7.57 (t, J = 7.4 
Hz, 1H), 7.51-7.43 (m, 4H), 7.38-7.26 (m, 4H), 7.25-7.18 (m, 2H), 6.95 (dt, J = 9.2, 2.4 Hz, 1H), 
6.51 (s, 1H), 3.79 (s, 3H).  13C NMR (100 MHz, Acetone-d6): δ 199.434, 160.701, 158.390, 
141.650, 138.918, 135.892, 134.804, 132.213, 131.005, 130.607, 130.503, 130.124, 128.577, 
114.655, 114.610, 112.504, 112.407, 111.596, 111.333, 105.730, 105.493, 51.711, 34.147.  19F 
NMR (400 MHz, Acetone-d6): d -127.026, -127.037, -127.052, -127.063, -127.077, -127.089. 
HRMS (ESI) Calcd for C23H19FNO ([M+H]+) 344.14452, Found 344.14425. 
 
2-(5-chloro-1-methyl-1H-indol-3-yl)-1,2-diphenylethanone (2k): 86% yield, 94% ee. 
Enantiomeric excess was determined by chiral HPLC analysis (Chiralcel OD-H column, 1.0 
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mL/min, 90:10 hexanes/iPrOH): tR(major) = 9.93 min, tR(minor) = 8.81 min. [a]23D = -221.81° (c 
= 0.535, THF).  1H NMR (400 MHz, Acetone-d6): δ 8.18 (d, J = 7.2 Hz, 2H), 7.63 (d, J = 1.6 Hz, 
1H), 7.57 (t, J = 7.4 Hz, 1H), 7.52-7.42 (m, 4H), 7.37 (d, J = 8.8 Hz, 1H), 7.30 (t, J = 7.4 Hz, 
2H), 7.24-7.17 (m, 2H), 7.14 (dd, J = 8.6, 1.80 Hz, 1H), 6.55 (s, 1H), 3.79 (s, 3H).  13C NMR 
(100 MHz, Acetone-d6): δ 199.391, 141.535, 138.801, 137.617, 134.838, 132.014, 130.967, 
130.634, 130.503, 130.161, 128.621, 126.303, 123.449, 120.200, 114.451, 112.893, 51.539, 
34.066. HRMS (ESI) Calcd for C23H19ClNO ([M+H]+) 360.11497, Found 344.11514. 
 
2-(5-bromo-1-methyl-1H-indol-3-yl)-1,2-diphenylethanone (2l): 86% yield, 96% ee. 
Enantiomeric excess was determined by chiral HPLC analysis (Chiralcel AS-H column, 1.0 
mL/min, 90:10 hexanes/iPrOH): tR(major) = 14.97 min, tR(minor) = 11.21 min. [a]23D = -183.03° 
(c = 0.510, THF).  1H NMR (400 MHz, Acetone-d6): δ 8.18 (d, J = 7.6 Hz, 2H), 7.78 (d, J = 1.6 
Hz, 1H), 7.58 (t, J = 7.2 Hz, 1H), 7.48 (t, J = 8.0 Hz, 4H), 7.36-7.26 (m, 3H), 7.25-7.18 (m, 3H), 
6.56 (s, 1H), 3.80 (s, 3H).  13C NMR (100 MHz, Acetone-d6): δ 199.401, 141.549, 138.842, 
137.889, 134.851, 131.900, 130.980, 130.661, 130.521, 130.185, 128.645, 126.064, 123.315, 
114.428, 113.920, 113.357, 51.550, 34.076. HRMS (ESI) Calcd for C23H19BrNO ([M+H]+) 
404.06445, Found 404.06643. 
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2-(1,5-dimethyl-1H-indol-3-yl)-1,2-diphenylethanone (2m): 95% yield, 94% ee. 
Enantiomeric excess was determined by chiral HPLC analysis (Chiralcel AD-H column, 1.0 
mL/min, 90:10 hexanes/iPrOH): tR(major) = 12.91 min, tR(minor) = 11.64 min. [a]23D = -319.44° 
(c = 0.480, THF).  1H NMR (400 MHz, Acetone-d6): δ 8.14 (d, J = 7.6 Hz, 2H), 7.55 (t, J = 7.4 
Hz, 1H), 7.49-7.38 (m, 5H), 7.31-7.16 (m, 4H), 7.05-6.96 (m, 2H), 6.48 (s, 1H), 3.73 (s, 3H), 
2.36 (s, 3H).  13C NMR (100 MHz, Acetone-d6): δ 199.465, 141.898, 139.036, 137.731, 134.650, 
131.082, 130.529, 130.442, 130.273, 129.965, 129.722, 129.320, 128.430, 125.122, 120.311, 
113.922, 111.110, 51.850, 33.835, 22.592. HRMS (ESI) Calcd for C24H22NO ([M+H]+) 
340.16959, Found 340.17060. 
 
2-(5-methoxy-1-methyl-1H-indol-3-yl)-1,2-diphenylethanone (2n): 83% yield, 96% ee. 
Enantiomeric excess was determined by chiral HPLC analysis (Chiralcel OD-H column, 1.0 
mL/min, 90:10 hexanes/iPrOH): tR(major) = 14.03 min, tR(minor) = 11.21 min. [a]23D = -307.24° 
(c = 0.430, THF).  1H NMR (400 MHz, Acetone-d6): δ 8.15 (d, J = 7.2, 2H), 7.56 (t, J = 7.4 Hz, 
1H), 7.49-7.42 (m, 4H), 7.32-7.18 (m, 4H), 7.14 (d, J = 2.4 Hz, 1H), 7.07 (s, 1H), 6.82 (dd, J = 
8.8, 2.4 Hz, 1H), 6.48 (s, 1H), 3.74 (s, 3H), 3.74 (s, 3H).  13C NMR (100 MHz, Acetone-d6): δ 
199.518, 156.047, 141.926, 139.116, 134.660, 131.100, 130.772, 130.536, 130.450, 130.127, 
129.964, 129.521, 128.422, 113.942, 113.405, 112.073, 102.956, 56.932, 51.871, 33.989. HRMS 
(ESI) Calcd for C24H22NO2 ([M+H]+) 356.16451, Found 356.16502. 
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4.2 Experimental procedures for Chapter 2 
4.2.1 General consideration 
All reactions were carried out in screw-cap test tubes with magnetic stirring. Anhydrous 
dichloromethane and methanol were purchased from Sigma-Aldrich and used without further 
purification. Molecular Sieves were flame-dried under high vacuum before use. Keto eaters and 
benzyl-protected isatins were purchased from commercial sources or prepared according to the 
literatures.1 
Thin layer chromatography was performed on Merck TLC plates (silica gel 60 F254). Flash 
column chromatography was performed with Merck silica gel (230-400 mesh). Enantiomeric 
excess (ee) was determined using a Varian Prostar HPLC with a 210 binary pump and a 335 
diode-array detector. Column conditions are reported in the experimental section below. Optical 
rotations were performed on a Rudolph Research Analytical Autopol IV polarimeter (λ 589) 
using a 700 µL cell with a path length of 1 dm. 1H NMR was recorded on a Varian Inova 600 
Spectrometer (600 MHz for 1H) or a Varian Inova 500 Spectrometer (500 MHz for 1H) or a 
Varian Inova 400 Spectrometer (400 MHz for 1H) or a Bruker Avance DPX-250 instrument (250 
MHz for 1H). 13C NMR was recorded on a Bruker Avance DPX-250 instrument (62.5 MHz for 
13C) or a Varian Inova 400 Sectrometer (100 MHz for 13C) or a Varian Inova 500 Spectrometer 
(125 MHz for 13C). 1H and 13C chemical shifts are reported in ppm downfield from 
tetramethylsilane (TMS). The HRMS data were measured on an Agilent 1100 LC/MS ESI/TOF 
mass spectrometer with electrospray ionization. MALDI-MS data was measured on a Bruker 
Daltconics MALDI/TOF Autoflex spectrometer using Nitrogen laser. Compounds described in 
the literature were characterized by comparing their spectral data to the reported values. The 
absolute configuration of 7b was determined by X-ray structure analysis. The absolute 
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configurations of all the other compounds were tentatively assigned by analogy. The SERS 
experiments were carried out on the Raman setup. The exposure time was 10 s and accumulation 
number was 3. The Raman spectra were measured in frequency range from 1400 to 2100 cm-1. 
4.2.2 Procedure for the preparation of catalyst Ca[P6]2 
To a flame-dried 50 mL flask was added 120 mg (R)-1-naphthyl-BINOL phosphoric acid2 
(0.2 mmol) and 10.2 mg Ca(OMe)2 (0.1 mmol), followed by 10 mL anhydrous MeOH and 10 
mL anhydrous DCM. The mixture was stirred overnight at room temperature. Then solvent was 
removed to afford the Ca[P6]2 as a white solid. 1H NMR (600 MHz, Acetone-d6) δ 8.5 - 7.0 
(m,48H) 13C NMR (62.5 MHz, CDCl3) δ 148.62, 148.47, 136.38, 134.11 134.02, 133.54, 133.24, 
132.90, 131.40, 129.82, 129.04, 128.96, 127.92, 127.50, 127.07, 126.61, 126.12, 123.63. 
MALDI-MS [M+H]+: Found 1239.615 with α-cyano-4-hydroxy-cinnamic acid as matrix. 
4.2.3 General procedure for asymmetric HDA reaction of α-keto esters and isatins 
To a test tube was weighted 80 mg Molecular Sieves (4Å), 6.2 mg Ca[P6]2 (2.5 mol%), 0.2 
mmol α-keto ester 3 or isatin 6, followed by 4 mL of DCM. Then 0.26 mmol of Danishefsky’s 
diene was added via micro syringe at room temperature. The mixture was stirred at room 
temperature for indicated time, after which it was cooled down to 0°C and 2 mL of 2.0 M HCl 
aqueous solution (or two drops of TFA) was added. The mixture was allowed to warm to room 
temperature in 1 h, and stirred for another 1 hour at room temperature. The reaction was 
quenched by 1.0 M NaHCO3 aqueous solution and the aqueous layer was washed with DCM (2 x 
2.0 mL) and the combined organic layers were dried over Na2SO4 and concentrated under 
reduced pressure to afford oil, which is purified by silica gel chromatography (6:1 Hexane:EA) 
to deliver the desired product. 
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(S)-Ethyl 2-methyl-4-oxo-3,4-dihydro-2H-pyran-2-carboxylate (5a)3: 95% yield, 99% ee. 
Enantiomeric excess was determined by chiral HPLC analysis (Chiralcel AD-H, 1.0 mL/min, 
90:10 hexanes/iPrOH): tR(major) = 7.52 min, tR(minor) = 6.89 min. [α]25D= +110.2° (c = 0.293 
CHCl3). 1H NMR (600 MHz, CDCl3) δ 7.33 (d, J = 6.0 Hz, 1H), 5.40 (dd, J = 6.0 Hz, 0.8 Hz, 
1H), 4.20 (q, J = 7.1 Hz, 2H), 2.99 (dd, J = 16.5 Hz, 0.8 Hz, 1H), 2.66 (d, J = 16.8 Hz, 1H), 1.63 
(s, 3H), 1.24 (t, J = 7.1 Hz, 3H). 13C NMR (62.5 MHz, CDCl3) δ 190.4, 170.5, 161.1, 107.3, 
83.1, 61.9, 44.4, 24.5, 14.2. 1H NMR and 13C NMR match the reported value. 
  
Ethyl 2-ethyl-4-oxo-3,4-dihydro-2H-pyran-2-carboxylate (5b): 95 % yield, 99% ee. 
Enantiomeric excess was determined by chiral HPLC analysis (Chiralcel AD-H, 1.0 mL/min, 
90:10 hexanes/iPrOH): tR(major) = 6.67 min, tR(minor) = 6.20 min. [α]25D= +164.5° (c = 0.295 
CHCl3). 1H NMR (600 MHz, CDCl3) δ 7.34 (d, J = 6.1 Hz, 1H), 5.37 (dd, J = 6.1, 1.0 Hz, 1H), 
4.18 (q, J = 7.1 Hz, 2H), 2.89 (dd, J = 16.8, 1.0 Hz, 1H), 2.67 (d, J = 16.7 Hz, 1H), 1.94 (q, J = 
7.5 Hz, 2H), 1.22 (t, J = 7.1 Hz, 3H), 0.94 (t, J = 7.5 Hz, 3H). 13C NMR (62.5 MHz, CDCl3) δ 
190.42, 170.62, 162.29, 107.55, 86.04, 62.36, 43.12, 30.83, 14.26, 7.73. HRMS (ESI) Calcd for 
[M+H]+ 199.09649, Found 199.09701. 
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Ethyl 2-hexyl-4-oxo-3,4-dihydro-2H-pyran-2-carboxylate (5c): 94% yield, 99% ee. 
Enantiomeric excess was determined by chiral HPLC analysis (Chiralcel AD-H, 1.0 mL/min, 
90:10 hexanes/iPrOH): tR(major) = 5.69 min, tR(minor) = 5.11 min. [α]25D= +101.4° (c = 0.455 
CHCl3). 1H NMR (600 MHz, CDCl3) δ 7.35 (d, J = 6.0 Hz, 1H), 5.38 (d, J = 6.0 Hz, 1H), 4.19 
(q, J = 7.2 Hz, 2H), 2.91 (d, J = 16.7 Hz, 1H), 2.69 (d, J = 16.7 Hz, 1H), 1.89 (dd, J = 8.7, 7.2 Hz, 
2H), 1.32 - 1.22 (m, 11H), 0.85 (t, J = 6.8 Hz, 3H). 13C NMR (62.5 MHz, CDCl3) δ 190.47, 
170.76, 162.31, 107.59, 85.83, 62.41, 43.56, 37.68, 31.64, 29.21, 23.24, 22.65, 14.31, 14.20. 
HRMS (ESI) Calcd for [M+H]+ 255.15909, Found 255.15915. 
 
(R)-ethyl 2-isopropyl-4-oxo-3,4-dihydro-2H-pyran-2-carboxylate (5d): 95% yield, 90% 
ee. Enantiomeric excess was determined by chiral HPLC analysis (Chiralcel AD-H, 1.0 mL/min, 
90:10 hexanes/iPrOH): tR(major) = 6.19 min, tR(minor) = 5.71 min. [α]25D= +155.6° (c = 0.310 
CHCl3). 1H NMR (600 MHz, CDCl3) δ 7.37 (d, J = 6.0 Hz, 1H), 5.38 (d, J = 6.0 Hz, 1H), 4.20 
(q, J = 7.2 Hz, 2H), 2.87 (d, J = 16.5 Hz, 1H), 2.73 (d, J = 16.5 Hz, 1H), 2.20 (m, 1H),1.24 (t, J = 
7.2 Hz, 3H), 1.00 (d, J = 6.6 Hz, 3H), 0.98 (d, J = 7.2 Hz, 3H). 13C NMR (62.5 MHz, CDCl3) δ 
190.8, 170.6, 162.6, 107.7, 88.8, 62.3, 40.8, 35.0, 17.0, 16.8, 14.4. 
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Ethyl 2-benzyl-4-oxo-3,4-dihydro-2H-pyran-2-carboxylate (5e): 91% yield, 99% ee. 
Enantiomeric excess was determined by chiral HPLC analysis (Chiralcel AD-H, 1.0 mL/min, 
90:10 hexanes/iPrOH): tR(major) = 10.17 min, tR(minor) = 7.76 min. [α]25D= +103.8° (c = 0.240 
CHCl3). 1H NMR (600 MHz, CDCl3) δ 7.31 (d, J = 6.3 Hz, 1H), 7.28b- 7.20 (m, 3H), 7.17 - 7.11 
(m, 2H), 5.33 (dd, J = 6.1, 1.0 Hz, 1H), 4.09 (q, J = 7.2 Hz, 2H), 3.22 (d, J = 14.0 Hz, 1H), 3.09 
(d, J = 14.0 Hz, 1H), 2.89 (dd, J = 16.7, 1.0 Hz, 1H), 2.62 (d, J = 16.8 Hz, 1H), 1.12 (t, J = 7.1 
Hz, 3H). 13C NMR (62.5 MHz, CDCl3) δ 190.14, 170.30, 161.92, 133.58, 130.49, 128.49, 
127.64, 107.55, 85.70, 62.42, 43.33, 42.72, 14.02. HRMS (ESI) Calcd for [M+H]+ 261.11214, 
Found 261.11234. 
 
Ethyl 4-oxo-2-phenethyl-3,4-dihydro-2H-pyran-2-carboxylate (5f): 94% yield, 96% ee. 
Enantiomeric excess was determined by chiral HPLC analysis (Chiralcel AD-H, 1.0 mL/min, 
90:10 hexanes/iPrOH): tR(major) = 9.08 min, tR(minor) = 7.64 min. [α]25D= +58.5° (c = 0.520 
CHCl3). 1H NMR (250 MHz, CDCl3) δ 7.40 (d, J = 6.1 Hz, 1H), 7.27 (t, J = 7.2 Hz, 2H), 7.19 (t, 
J = 7.4 Hz, 1H), 7.15 (d, J = 7.4 Hz, 2H), 5.43 (dd, J = 6.1, 0.9 Hz, 1H), 4.19 (q, J = 6.9 Hz, 2H), 
2.97 (d, J = 16.7 Hz, 1H), 2.84 - 2.78 (m, 1H), 2.76 (d, J = 16.8 Hz, 1H), 2.66 - 2.57 (m, 1H), 
2.27 - 2.21 (m, 2H), 1.25 (t, J = 7.1 Hz, 3H). 13C NMR (62.5 MHz, CDCl3) δ 190.10, 170.41, 
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162.21, 140.35, 128.78, 128.49, 126.55, 107.72, 85.33, 62.58, 43.65, 39.42, 29.67, 14.33. HRMS 
(ESI) Calcd for [M+H]+ 275.12779, Found 275.12848. 
 
(E)-ethyl 4-oxo-2-styryl-3,4-dihydro-2H-pyran-2-carboxylate (5g): 92% yield, 98% ee. 
Enantiomeric excess was determined by chiral HPLC analysis (Chiralcel AD-H, 1.0 mL/min, 
90:10 hexanes/iPrOH): tR(major) = 13.04 min, tR(minor) = 9.61 min. [α]25D= -32.5° (c = 0.305 
CHCl3). 1H NMR (600 MHz, CDCl3) δ 7.43 (d, J = 6.0 Hz, 1H), 7.38 (d, J = 7.8 Hz, 2H), 7.32 (t, 
J = 7.6 Hz, 2H), 7.28 (d, J = 7.8 Hz, 1H), 6.80 (d, J = 16.1 Hz, 1H), 6.23 (d, J = 16.1 Hz, 1H), 
5.47 (d, J = 6.1 Hz, 1H), 4.24 (qd, J = 7.2, 2.4 Hz, 2H), 3.19 (d, J = 16.7 Hz, 1H), 2.90 (d, J = 
16.7 Hz, 1H), 1.26 (t, J = 7.1 Hz, 3H). 13C NMR (62.5 MHz, CDCl3) δ 189.68, 169.16, 161.37, 
135.11, 133.05, 128.85, 128.80, 126.94, 124.42, 108.08, 84.71, 62.83, 43.58, 14.10. HRMS 
(ESI) Calcd for [M+H]+ 273.11214, Found 273.11313. 
 
Ethyl 4-oxo-2-((trimethylsilyl)ethynyl)-3,4-dihydro-2H-pyran-2-carboxylate (5h): 76% 
yield, 99% ee. Enantiomeric excess was determined by chiral HPLC analysis (Chiralcel AD-H, 
1.0 mL/min, 99:1 hexanes/iPrOH): tR(major) = 9.64 min, tR(minor) = 8.56 min. [α]25D= -90.4° (c 
= 0.350 CHCl3). 1H NMR (600 MHz, CDCl3) δ 7.29 (d, J = 6.2 Hz, 1H), 5.48 (d, J = 6.2 Hz, 
1H), 4.30 (qd, J = 7.1, 2.3 Hz, 2H), 3.09 (d, J = 16.7 Hz, 1H), 2.96 (d, J = 16.7 Hz, 1H), 1.29 (t, 
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J = 7.1 Hz, 3H), 0.15 (s, 9H) 13C NMR (62.5 MHz, CDCl3) δ 189.30, 166,69, 161.04, 108.56, 
98.11, 95.12, 78.27, 63.93, 45.21, 14.47, 0.02. HRMS (ESI) Calcd for [M+H]+ 267.10471, 
Found 267.10469. 
 
(R)-Ethyl 4-oxo-2-phenyl-3,4-dihydro-2H-pyran-2-carboxylate (5i):3 96% yield, 98% ee. 
Enantiomeric excess was determined by chiral HPLC analysis (Chiralcel AD-H, 1.0 mL/min, 
97:3 hexanes/iPrOH): tR(major) = 14.63 min, tR(minor) = 13.57 min. [α]25D= +48.6° (c = 0.325 
CHCl3). 1H NMR (250 MHz, CDCl3) δ 7.57 - 7.50 (m, 3H), 7.44 - 7.36 (m, 3H), 5.49 (dd, J = 
6.0, 1.0 Hz, 1H), 4.20 (qd, J = 7.2, 1.0 Hz, 2H), 3.51 (dd, J = 16.6, 1.0 Hz, 1H), 3.09 (d, J = 16.6 
Hz, 1H), 1.21 (t, J = 7.2 Hz, 3H). 13C NMR (62.5 MHz, CDCl3) δ 189.84, 169.55, 161.55, 
136.71, 129.17, 128.89, 124.99, 108.37, 85.70, 62.76, 44.34, 13.94. 1H NMR and 13C NMR 
match the reported value. 
 
Ethyl 2-(4-fluorophenyl)-4-oxo-3,4-dihydro-2H-pyran-2-carboxylate (5j): 95% yield, 
98% ee. Enantiomeric excess was determined by chiral HPLC analysis (Chiralcel AD-H, 1.0 
mL/min, 90:10 hexanes/iPrOH): tR(major) = 8.67 min, tR(minor) = 7.88 min. [α]25D= +39.2° (c = 
0.405 CHCl3). 1H NMR (600 MHz, CDCl3) δ 7.50 - 7.47 (m, 2H), 7.46 (d, J = 6.1 Hz, 1H), 7.07 
(t, J = 8.6 Hz, 2H), 5.48 (d, J = 6.1 Hz, 1H), 4.17 (qd, J = 7.1, 2.0 Hz, 2H), 3.40 (d, J = 16.6 Hz, 
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1H), 3.01 (d, J = 16.6 Hz, 1H), 1.17 (t, J = 7.1 Hz, 3H). 13C NMR (62.5 MHz, CDCl3) δ 189.68, 
169.54, 165.16, 161.54, 161.20, 132.77, 132.72, 127.30, 127.17, 116.22, 115.88, 108.58, 85.37, 
63.02, 44.43, 14.09. HRMS (ESI) Calcd for [M+H]+ 265.08706, Found 265.08835. 
 
Ethyl 2-(4-chlorophenyl)-4-oxo-3,4-dihydro-2H-pyran-2-carboxylate (5k): 96% yield, 
98% ee. Enantiomeric excess was determined by chiral HPLC analysis (Chiralcel AD-H, 1.0 
mL/min, 90:10 hexanes/iPrOH): tR(major) = 9.32 min, tR(minor) = 8.52 min. [α]25D= +22.7° (c = 
0.465 CHCl3). 1H NMR (600 MHz, CDCl3) δ 7.46 (d, J = 6.1 Hz, 1H), 7.44 (d, J = 8.7 Hz, 2H), 
7.36 (d, J = 8.7 Hz, 2H), 5.49 (d, J = 6.0 Hz, 1H), 4.17 (q, J = 7.1 Hz, 2H), 3.39 (d, J = 16.7 Hz, 
1H), 2.99 (d, J = 16.6 Hz, 1H), 1.17 (t, J = 7.1 Hz, 3H). 13C NMR (62.5 MHz, CDCl3) δ 189.53, 
169.36, 161.47, 135.46, 135.43, 129.26, 126.66, 108.64, 85.36, 63.11, 44.38, 14.10. HRMS 
(ESI) Calcd for [M+H]+ 281.05751, Found 281.05741. 
 
Ethyl 2-(4-bromophenyl)-4-oxo-3,4-dihydro-2H-pyran-2-carboxylate (5l): 97% yield, 
98% ee. Enantiomeric excess was determined by chiral HPLC analysis (Chiralcel AD-H, 1.0 
mL/min, 90:10 hexanes/iPrOH): tR(major) = 9.49 min, tR(minor) = 8.71 min. [α]25D= +12.5° (c = 
0.665 CHCl3). 1H NMR (600 MHz, CDCl3) δ 7.51 (d, J = 8.6 Hz, 2H), 7.46 (d, J = 6.1 Hz, 1H), 
7.38 (d, J = 8.5 Hz, 2H), 5.49 (d, J = 6.1 Hz, 1H), 4.17 (q, J = 7.2 Hz, 2H), 3.39 (d, J = 16.6 Hz, 
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1H), 2.99 (d, J = 16.6 Hz, 1H), 1.17 (t, J = 7.1 Hz, 3H). 13C NMR (62.5 MHz, CDCl3) δ 189.34, 
169.14, 161.30, 135.82, 132.08, 126.78, 123.52, 108.50, 85.25, 62.98, 44.20, 13.96. HRMS 
(ESI) Calcd for [M+H]+ 325.00700, Found 325.00649. 
 
Ethyl 2-(4-methoxyphenyl)-4-oxo-3,4-dihydro-2H-pyran-2-carboxylate (5m): 96% yield, 
99% ee. Enantiomeric excess was determined by chiral HPLC analysis (Chiralcel AD-H, 1.0 
mL/min, 90:10 hexanes/iPrOH): tR(major) = 12.27 min, tR(minor) = 11.36 min. [α]25D= -26.9° (c 
= 0.530 CHCl3). 1H NMR (600 MHz, CDCl3) δ 7.45 (d, J = 6.1 Hz, 1H), 7.43 - 7.40 (m, 2H), 
6.91 - 6.88 (m, 2H), 5.47 (d, J = 6.1 Hz, 1H), 4.20 - 4.13 (m, 2H), 3.78 (s, 3H), 3.38 (d, J = 16.6 
Hz, 1H), 3.05 (d, J = 16.6 Hz, 1H), 1.17 (t, J = 7.1 Hz, 3H). 13C NMR (62.5 MHz, CDCl3) δ 
190.16, 169.88, 161.74, 160.30, 128.76, 126.71, 114.34, 108.42, 85.57, 62.80, 55.51, 44.21, 
14.12. HRMS (ESI) Calcd for [M+H]+ 277.10705, Found 277.10810. 
 
Ethyl 2-(naphthalen-2-yl)-4-oxo-3,4-dihydro-2H-pyran-2-carboxylate (5n): 91% yield, 
99% ee. Enantiomeric excess was determined by chiral HPLC analysis (Chiralcel AD-H, 1.0 
mL/min, 90:10 hexanes/iPrOH): tR(major) = 12.68 min, tR(minor) = 11.03 min. [α]25D= -30.4° (c 
= 0.585 CHCl3). 1H NMR (400 MHz, CDCl3) δ 7.98 (d, J = 2.0 Hz, 1H), 7.88 - 7.82 (m, 3H), 
7.60 (dd, J = 8.8 Hz, 2.0 Hz, 1H), 7.54 - 7.49 (m, 3H), 5.52 (dd, J = 6.0 Hz, 0.8 Hz, 1H), 4.19 
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(qd, J = 7.2 Hz, 1.6 Hz 2H), 3.53 (d, J = 17.6 Hz, 1H), 3.17 (d, J = 16.8 Hz, 1H), 1.18 (t, J = 7.2 
Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 189.69, 169.46, 161.38, 133.89, 133.25, 132.83, 128.82, 
128.43, 127.59, 126.99 126.71, 124.69, 122.21, 108.40, 85.79, 62.79, 44.28, 13.91. HRMS (ESI) 
Calcd for [M+H]+ 297.11213, Found 297.11195. 
 
Ethyl 2-(furan-2-yl)-4-oxo-3,4-dihydro-2H-pyran-2-carboxylate (5o): 83% yield, 98% ee. 
Enantiomeric excess was determined by chiral HPLC analysis (Chiralcel OD-H, 1.0 mL/min, 
95:5 hexanes/iPrOH): tR(major) = 16.80 min, tR(minor) = 18.11 min. [α]25D= -153.2° (c = 0.215 
CHCl3). 1H NMR (400 MHz, CDCl3) δ 7.44 (dd, J = 2.0 Hz, 0.8 Hz, 1H), 7.35 (d, J = 6.0 Hz, 
1H), 6.47 (dd, J = 3.2 Hz, 0.8 Hz, 1H), 6.39 (dd, J = 3.2 Hz, 2.0 Hz, 1H), 5.47 (d, J = 6.0 Hz, 
1H), 4.31 - 4.23 (m, 2H), 3.27 (d, J = 16.8 Hz, 1H), 3.21 (dd, J = 16.8 Hz, 0.8 Hz, 1H), 1.25 (t, J 
= 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 189.02, 167.46, 160.86, 148.31, 143.93, 110.78, 
110.25, 107.85, 81.26, 63.00, 41.45, 13.94. HRMS (ESI) Calcd for [M+H]+ 237.07575, Found 
237.07541. 
 
Ethyl 4-oxo-2-(thiophen-2-yl)-3,4-dihydro-2H-pyran-2-carboxylate (5p): 99% yield, 99% 
ee. Enantiomeric excess was determined by chiral HPLC analysis (Chiralcel OD-H, 0.7 mL/min, 
90:10 hexanes/iPrOH): tR(major) = 17.55 min, tR(minor) = 19.21 min. [α]25D= -41.6° (c = 0.625 
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CHCl3). 1H NMR (400 MHz, CDCl3) δ 7.41 (dd, J = 6.2 Hz, 1.2 Hz, 1H), 7.35 (dt, J = 5.2 Hz, 
1.2 Hz, 1H), 7.12 (dt, J = 3.6 Hz, 1.2 Hz, 1H), 7.00 (ddd, J = 5.2 Hz, 2.8 Hz, 0.8 Hz, 1H), 5.49 
(d, J = 6.0 Hz, 1H), 4.29 - 4.17 (m, 2H), 3.41 (d, J = 16.8 Hz, 1H), 3.19 (dd, J = 17.6 Hz, 1.2 Hz, 
1H), 1.23 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 189.09, 168.52, 161.03, 139.54, 
127.04, 127.01, 126.18, 108.23, 83.82, 62.99, 44.60, 13.88. HRMS (ESI) Calcd for [M+H]+ 
253.05290, Found 253.05301. 
 
1-benzylspiro[indoline-3,2'-pyran]-2,4'(3'H)-dione (7a): 95% yield, 99% ee. Enantiomeric 
excess was determined by chiral HPLC analysis (Chiralcel AD-H, 1.0 mL/min, 90:10 
hexanes/iPrOH): tR(major) = 21.57 min, tR(minor) = 23.61 min. [α]25D= -276.6° (c = 0.430 
CHCl3). 1H NMR (400 MHz, CDCl3) δ 7.46 (ddd, J = 7.5, 1.2, 0.5 Hz, 1H), 7.39 (d, J = 6.2 Hz, 
1H), 7.32 - 7.28 (m, 2H), 7.27 - 7.22 (m, 4H), 7.00 (td, J = 7.6, 1.0 Hz, 1H), 6.73 (d, J = 7.8 Hz, 
1H), 5.61 (dd, J = 6.2, 0.7 Hz, 1H), 4.90 (d, J = 15.7 Hz, 1H), 4.85 (d, J = 15.7 Hz, 1H), 3.22 (d, 
J = 16.6 Hz, 1H), 2.70 (dd, J = 16.6, 0.7 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 189.12, 
172.11, 161.33, 142.07, 134.72, 131.19, 128.94, 127.94, 127.41, 127.14, 124.35, 123.59, 110.06, 
106.95, 81.36, 43.92, 41.40. HRMS (ESI) Calcd for [M+H]+ 306.11320, Found 306.30841. 
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1-benzyl-4-chlorospiro[indoline-3,2'-pyran]-2,4'(3'H)-dione (7b): 96% yield, 99% ee. 
Enantiomeric excess was determined by chiral HPLC analysis (Chiralcel OD-H, 0.7 mL/min, 
90:10 hexanes/iPrOH): tR(major) = 51.07 min, tR(minor) = 58.12 min. [α]25D= +156.7° (c = 0.570 
CHCl3). 1H NMR (600 MHz, CDCl3) δ 7.38 (d, J = 6.3 Hz, 1H), 7.30 (t, J = 7.2 Hz, 2H), 7.26 (d, 
J = 7.0 Hz, 1H), 7.22 (d, J = 7.6 Hz, 2H), 7.19 (t, J = 8.1 Hz, 1H), 7.02 (d, J = 8.2 Hz, 1H), 6.62 
(d, J = 7.9 Hz, 1H), 5.58 (d, J = 6.3 Hz, 1H), 4.83 (d, J = 15.7 Hz, 1H), 4.79 (d, J = 15.7 Hz, 1H), 
3.74 (d, J = 17.2 Hz, 1H), 2.60 (d, J = 17.2 Hz, 1H). 13C NMR (62.5 MHz, CDCl3) δ 189.15, 
172.83, 160.87, 144.44, 134.64, 132.46, 132.44, 129.25, 128.32, 127.43, 124.89, 123.05, 108.67, 
106.78, 81.42, 44.05, 38.59. HRMS (ESI) Calcd for [M+H]+ 340.07350, Found 340.07278. 
 
1-benzyl-5-methoxyspiro[indoline-3,2'-pyran]-2,4'(3'H)-dione (7c): 98% yield, 96% ee. 
Enantiomeric excess was determined by chiral HPLC analysis (Regis Pirkle Covalent (S,S) 
Whelk-O1 FEL, 1.0 mL/min, 55:45 hexanes/iPrOH): tR(major) = 23.35 min, tR(minor) = 26.56 
min. [α]25D= -122.6° (c = 0.910 CHCl3). 1H NMR (400 MHz, CDCl3) δ 7.39 (d, J = 6.2 Hz, 1H), 
7.33 - 7.27 (m, 2H), 7.27 - 7.22 (m, 3H), 7.06 (d, J = 2.5 Hz, 1H), 6.75 (dd, J = 8.6, 2.6 Hz, 1H), 
6.62 (d, J = 8.6 Hz, 1H), 5.61 (d, J = 6.2 Hz, 1H), 4.87 (d, J = 15.7 Hz, 1H), 4.82 (d, J = 15.7 Hz, 
1H), 3.69 (s, 3H), 3.21 (d, J = 16.7 Hz, 1H), 2.70 (d, J = 16.7 Hz, 1H). 13C NMR (62.5 MHz, 
CDCl3) δ 189.14, 171.96, 161.42, 156.42, 135.23, 134.84, 129.00, 128.49, 127.99, 127.20, 
115.35, 111.78, 110.69, 107.01, 81.71, 55.87, 44.06, 41.53. HRMS (ESI) Calcd for [M+H]+ 
336.12303, Found 336.12247. 
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1-benzyl-5-fluorospiro[indoline-3,2'-pyran]-2,4'(3'H)-dione (7d): 95% yield, 93% ee. 
Enantiomeric excess was determined by chiral HPLC analysis (Chiralcel AD-H, 1.0 mL/min, 
90:10 hexanes/iPrOH): tR(major) = 34.05 min, tR(minor) = 23.16 min. [α]25D= -218.6° (c = 1.400 
CHCl3). 1H NMR (600 MHz, CDCl3) δ 7.40 (d, J = 6.1 Hz, 1H), 7.31 (t, J = 7.0 Hz, 2H), 7.27 (d, 
J = 6.9 Hz, 1H), 7.25 - 7.20 (m, 3H), 6.95 (t, J = 8.7 Hz, 1H), 6.65 (dd, J = 8.3, 3.7 Hz, 1H), 5.63 
(d, J = 6.1 Hz, 1H), 4.89 (d, J = 15.7 Hz, 1H), 4.85 (d, J = 15.7 Hz, 1H), 3.22 (d, J = 16.6 Hz, 
1H), 2.69 (d, J = 16.7 Hz, 1H). 13C NMR (62.5 MHz, CDCl3) δ 188.70, 171.94, 161.24, 161.15, 
157.27, 138.02, 137.98, 134.44, 129.10, 128.65, 128.53, 128.16, 127.17, 117.79, 117.42, 112.92, 
112.52, 111.03, 110.91, 107.16, 81.31, 44.13, 41.34. HRMS (ESI) Calcd for [M+H]+ 324.10305, 
Found 324.10286. 
 
1-benzyl-5-chlorospiro[indoline-3,2'-pyran]-2,4'(3'H)-dione (7e): 96% yield, 93% ee. 
Enantiomeric excess was determined by chiral HPLC analysis (Chiralcel AD-H, 1.0 mL/min, 
90:10 hexanes/iPrOH): tR(major) = 32.16 min, tR(minor) = 21.67 min. [α]25D= -291.1° (c = 0.620 
CHCl3). 1H NMR (600 MHz, CDCl3) δ 7.44 (s, 1H), 7.40 (d, J = 6.2 Hz, 1H), 7.31 (t, J = 7.5 Hz, 
2H), 7.27 (d, J = 6.7 Hz, 1H), 7.25 - 7.20 (m, 3H), 6.65 (d, J = 8.4 Hz, 1H), 5.64 (d, J = 6.2 Hz, 
1H), 4.89 (d, J = 15.7 Hz, 1H), 4.84 (d, J = 15.7 Hz, 1H), 3.21 (d, J = 16.7 Hz, 1H), 2.70 (d, J = 
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16.7 Hz, 1H). 13C NMR (62.5 MHz, CDCl3) δ 188.62, 171.76, 161.25, 140.61, 134.30, 131.16, 
129.13, 129.04, 128.83, 128.21, 127.16, 124.92, 111.22, 107.21, 81.15, 44.11, 41.28. HRMS 
(ESI) Calcd for [M+H]+ 340.07350, Found 340.07305. 
 
1-benzyl-5-bromospiro[indoline-3,2'-pyran]-2,4'(3'H)-dione (7f): 95% yield, 93% ee. 
Enantiomeric excess was determined by chiral HPLC analysis (Chiralcel AD-H, 1.0 mL/min, 
90:10 hexanes/iPrOH): tR(major) = 33.09 min, tR(minor) = 22.08 min. [α]25D= -299.1° (c = 0.650 
CHCl3). 1H NMR (600 MHz, CDCl3) δ 7.58 (s, 1H), 7.40 (d, J = 6.2 Hz, 1H), 7.37 (d, J = 8.3 
Hz, 1H), 7.31 (d, J = 7.2 Hz, 1H), 7.28 (d, J = 6.9 Hz, 1H), 7.24 - 7.20 (m, 3H), 6.60 (d, J = 8.3 
Hz, 1H), 5.64 (d, J = 6.0 Hz, 1H), 4.88 (d, J = 15.7 Hz, 1H), 4.84 (d, J = 15.7 Hz, 1H), 3.21 (d, J 
= 16.7 Hz, 1H), 2.70 (d, J = 16.7 Hz, 1H). 13C NMR (62.5 MHz, CDCl3) δ 188.58, 171.65, 
161.22, 141.12, 134.26, 134.09, 129.19, 129.13, 128.21, 127.61, 127.15, 116.23, 111.66, 107.22, 
81.09, 44.09, 41.27. HRMS (ESI) Calcd for [M+H]+ 384.02298, Found 384.02338. 
 
1-benzyl-6-bromospiro[indoline-3,2'-pyran]-2,4'(3'H)-dione (7g): 96% yield, 97% ee. 
Enantiomeric excess was determined by chiral HPLC analysis (Chiralcel AD-H, 1.0 mL/min, 
90:10 hexanes/iPrOH): tR(major) = 19.81 min, tR(minor) = 22.60 min. [α]25D= -238.9° (c = 0.820 
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CHCl3). 1H NMR (400 MHz, CDCl3) δ 7.38 (d, J = 6.4 Hz, 1H), 7.36 - 7.28 (m, 4H), 7.25 - 7.24 
(m, 1H), 7.24 - 7.23 (m, 1H), 7.15 (dd, J = 8.0, 1.6 Hz, 1H), 6.88 (d, J = 1.6 Hz, 1H), 5.62 (d, J = 
6.4 Hz, 1H), 4.88 (d, J = 16.0 Hz, 1H), 4.82 (d, J = 16.0 Hz, 1H), 3.20 (d, J = 16.8 Hz, 1H), 2.68 
(d, J = 17.2 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 188.64, 171.93, 161.12, 143.46, 134.18, 
129.10, 128.19, 127.10, 126.49, 126.22, 125.58, 125.11, 113.46, 107.06, 80.87, 44.04, 41.18. 
HRMS (ESI) Calcd for [M+H]+ 384.02298, Found 384.02311. 
 
1-benzyl-7-chlorospiro[indoline-3,2'-pyran]-2,4'(3'H)-dione (7h): 97% yield, 98% ee. 
Enantiomeric excess was determined by chiral HPLC analysis (Chiralcel AD-H, 1.0 mL/min, 
90:10 hexanes/iPrOH): tR(major) = 20.07 min, tR(minor) = 22.84 min. [α]25D= -148.3° (c = 0.775 
CHCl3). 1H NMR (400 MHz, CDCl3) δ 7.41 (dd, J = 7.6, 1.2 Hz, 1H), 7.38 (d, J = 6.4 Hz, 1H), 
7.32 - 7.24 (m, 3H), 7.23 - 7.17 (m, 3H), 6.97 (t, J = 8.0 Hz, 1H), 5.62 (d, J = 6.4 Hz, 1H), 5.34 
(d, J = 16.0 Hz, 1H), 5.29 (d, J = 16.4 Hz, 1H), 3.17 (d, J = 16.8 Hz, 1H), 2.75 (d, J = 16.4 Hz, 
1H). 13C NMR (100 MHz, CDCl3) δ 188.57, 172.86, 161.03, 138.32, 136.39, 133.76, 130.18, 
128.72, 127.48, 126.31, 124.63, 122.93, 116.40, 106.94, 80.47, 45.06, 41.45. HRMS (ESI) Calcd 
for [M+H]+ 340.07350, Found 340.07352. 
4.3 Experimental procedures for Chapter 3 
The β,γ-unsaturated α-keto esters 14 were prepared according to the literature.4 And the rest 
remained the same with 4.2.1. 
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4.3.1 Procedure for the preparation of catalyst Mg[P18]2 
To a flame-dried 50 mL flask was added (R)-P18 (0.2 mmol) and Mg(O-tBu)2 (0.1 mmol), 
followed by 10 mL anhydrous MeOH and 10 mL anhydrous DCM. The mixture was stirred 
overnight at room temperature. Then solvent was removed to afford the Mg[P18]2 as a white 
solid. 
4.3.2 General procedure for asymmetric Mukaiyama-Michael reaction of β,γ-
unsaturated α-keto esters 
To a test tube was weighted 80 mg Molecular Sieves (4Å), 9.5 mg Mg[P18]2 (2.5 mol%), 0.2 
mmol keto ester 14, followed by 4 mL of cyclohexane. Then 0.22 mmol of 8 was added via 
micro syringe at room temperature or 10°C. The mixture was stirred at room temperature for 
indicated time, after which cyclohexane was removed and replaced by 3 mL of THF. 0.2 mL of 
2.0 M HCl aqueous solution was added at 0°C. The mixture was allowed to warm to room 
temperature and stirred for 4 hours. The reaction was quenched by 1.0 M NaHCO3 aqueous 
solution and the aqueous layer was washed with diethyl ether (3 x 2.0 mL) and the combined 
organic layers were dried over Na2SO4 and concentrated under reduced pressure to afford oil, 
which is purified by silica gel chromatography (5:1 Hexane:EA) to deliver the desired product. 
 
Dimethyl 2-oxo-4-phenylhexanedioate (15a): 95% yield, 95% ee. Enantiomeric excess was 
determined by chiral HPLC analysis (Chiralcel OD-H, 1.0 mL/min, 90:10 hexanes/iPrOH): 
tR(major) = 21.63 min, tR(minor) = 17.64 min. [α]25D= +2.3° (c = 0.480 CHCl3). 1H NMR (400 
O
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MHz, CDCl3) δ 7.32 - 7.27 (m, 2H), 7.24 - 7.18 (m, 3H), 3.81 (s, 3H), 3.74 (p, J = 7.2 Hz, 1H), 
3.60 (s, 3H), 3.26 (qd, J = 15.5, 7.2 Hz, 2H), 2.69 (qd, J = 13.0, 7.6 Hz, 2H). 13C NMR (126 
MHz, CDCl3) δ 191.98, 171.98, 161.00, 142.35, 128.71, 127.25, 127.08, 53.00, 51.69, 45.08, 
40.30, 36.70. HRMS (ESI) Calcd for [M+H]+ 265.1071, Found 265.1079. 
 
Dimethyl 4-(furan-2-yl)-2-oxohexanedioate (15b): 91% yield, 95% ee. Enantiomeric 
excess was determined by chiral HPLC analysis (Chiralcel AD-H, 1.0 mL/min, 90:10 
hexanes/iPrOH): tR(major) = 9.61 min, tR(minor) = 10.59 min. [α]25D= +1.4° (c = 0.440 CHCl3). 
1H NMR (500 MHz, CDCl3) δ 7.29 (s, 1H), 6.26 (s, 1H), 6.07 (s, 1H), 3.90 - 3.80 (m, 4H), 3.65 
(s, 3H), 3.33 (dd, J = 18.0, 7.1 Hz, 1H), 3.21 (dd, J = 18.0, 6.6 Hz, 1H), 2.75 (dd, J = 15.9, 6.9 
Hz, 1H), 2.68 (dd, J = 15.9, 7.4 Hz, 1H). 13C NMR (126 MHz, cdcl3) δ 191.67, 171.75, 160.88, 
154.89, 141.59, 110.20, 105.63, 53.06, 51.81, 42.49, 37.56, 30.44. HRMS (ESI) Calcd for 
[M+H]+ 255.0863, Found 255.0871. 
 
Dimethyl 2-oxo-4-(thiophen-2-yl)hexanedioate (15c): 97% yield, 95% ee. Enantiomeric 
excess was determined by chiral HPLC analysis (Chiralcel OD-H, 1.0 mL/min, 95:05 
hexanes/iPrOH): tR(major) = 27.84 min, tR(minor) = 26.44 min. [α]25D= -1.7° (c = 0.470 CHCl3). 
1H NMR (500 MHz, CDCl3) δ 7.15 (dd, J = 5.0, 1.1 Hz, 1H), 6.92 - 6.87 (m, 2H), 4.09 (p, J = 
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7.1 Hz, 1H), 3.85 (s, 3H), 3.65 (s, 3H), 3.35 (dd, J = 18.1, 7.2 Hz, 1H), 3.29 (dd, J = 18.1, 6.7 
Hz, 1H), 2.75 (dd, J = 7.2, 1.0 Hz, 2H). 13C NMR (126 MHz, cdcl3) δ 191.52, 171.59, 160.87, 
145.69, 126.79, 124.46, 123.81, 53.08, 51.82, 45.81, 41.02, 32.09. HRMS (ESI) Calcd for 
[M+H]+ 271.0635, Found 271.0639. 
 
Dimethyl 4-(naphthalen-2-yl)-2-oxohexanedioate (15d): 95% yield, 92% ee. Enantiomeric 
excess was determined by chiral HPLC analysis (Chiralcel OD-H, 1.0 mL/min, 90:10 
hexanes/iPrOH): tR(major) = 27.72 min, tR(minor) = 22.25 min. [α]25D= +5.6° (c = 0.340 CHCl3). 
1H NMR (500 MHz, CDCl3) δ 7.80 (d, J = 8.4 Hz, 3H), 7.69 (s, 1H), 7.50 - 7.41 (m, 2H), 7.40 - 
7.35 (m, 1H), 3.94 (p, J = 7.2 Hz, 1H), 3.80 (s, 3H), 3.60 (s, 3H), 3.41 (dd, J = 17.9, 7.3 Hz, 1H), 
3.33 (dd, J = 17.9, 6.8 Hz, 1H), 2.85 - 2.73 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 191.95, 
171.96, 161.00, 139.77, 133.40, 132.53, 128.53, 127.76, 127.60, 126.19, 125.99, 125.80, 125.44, 
53.00, 51.74, 45.08, 40.27, 36.83. HRMS (ESI) Calcd for [M+H]+ 315.1227, Found 315.1215. 
 
Dimethyl 4-(4-fluorophenyl)-2-oxohexanedioate (15e): 92% yield, 96% ee. Enantiomeric 
excess was determined by chiral HPLC analysis (Regis Pirkle Covalent (S,S) Whelk-O1 FEL, 1.0 
mL/min, 90:10 hexanes/iPrOH): tR(major) = 27.33 min, tR(minor) = 22.38 min. [α]25D= +1.7° (c 
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= 0.290 CHCl3). 1H NMR (500 MHz, CDCl3) δ 7.21 (dd, J = 8.7, 5.3 Hz, 2H), 6.98 (t, J = 8.7 
Hz, 2H), 3.83 (s, 3H), 3.74 (p, J = 7.3 Hz, 1H), 3.60 (s, 3H), 3.27 (dd, J = 18.0, 7.5 Hz, 1H), 3.21 
(dd, J = 18.0, 6.7 Hz, 1H), 2.70 (dd, J = 15.7, 7.4 Hz, 1H), 2.63 (dd, J = 15.7, 7.6 Hz, 1H). 13C 
NMR (126 MHz, CDCl3) δ 191.80, 171.78, 162.71, 160.94, 160.76, 138.01, 137.98, 128.87, 
128.80, 115.62, 115.45, 53.05, 51.73, 45.11, 40.36, 35.98. HRMS (ESI) Calcd for [M+H]+ 
283.0976, Found 283.0965. 
 
Dimethyl 4-(4-chlorophenyl)-2-oxohexanedioate (15f): 92% yield, 98% ee. Enantiomeric 
excess was determined by chiral HPLC analysis (Chiralcel OD-H, 0.5 mL/min, 90:10 
hexanes/iPrOH): tR(major) = 32.27 min, tR(minor) = 31.02 min. [α]25D= +4.3° (c = 0.400 CHCl3). 
1H NMR (500 MHz, CDCl3) δ 7.29 - 7.27 (m, J = 3.5 Hz, 1H), 7.26 (d, J = 2.3 Hz, 1H), 7.19 (d, 
J = 2.2 Hz, 1H), 7.17 (d, J = 2.1 Hz, 1H), 3.83 (s, 3H), 3.76 - 3.69 (m, 1H), 3.60 (s, 3H), 3.31 - 
3.17 (m, 2H), 2.70 (ddd, J = 15.8, 7.3, 2.2 Hz, 1H), 2.63 (ddd, J = 15.8, 7.6, 2.3 Hz, 1H). 13C 
NMR (126 MHz, CDCl3) δ 191.67, 171.69, 160.90, 140.79, 132.83, 128.85, 128.71, 53.08, 
51.77, 44.92, 40.12, 36.05. HRMS (ESI) Calcd for [M+H]+ 299.0681, Found 299.0668. 
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Dimethyl 4-(4-bromophenyl)-2-oxohexanedioate (15g): 92% yield, 96% ee. Enantiomeric 
excess was determined by chiral HPLC analysis (Chiralcel OD-H, 1.0 mL/min, 90:10 
hexanes/iPrOH): tR(major) = 17.68 min, tR(minor) = 16.09 min. [α]25D= +4.5° (c = 0.360 CHCl3). 
1H NMR (400 MHz, CDCl3) δ 7.41 (d, J = 8.1 Hz, 2H), 7.12 (d, J = 8.2 Hz, 2H), 3.82 (s, 3H), 
3.71 (p, J = 7.3 Hz, 1H), 3.60 (s, 3H), 3.31 - 3.16 (m, 2H), 2.69 (dd, J = 15.7, 7.3 Hz, 1H), 2.62 
(dd, J = 15.7, 7.5 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 191.62, 171.63, 160.89, 141.32, 
131.79, 129.07, 120.90, 53.05, 51.74, 44.84, 40.02, 36.10. HRMS (ESI) Calcd for [M+H]+ 
343.0176, Found 343.0182. 
 
Dimethyl 4-(4-methoxyphenyl)-2-oxohexanedioate (15h): 98% yield, 94% ee. 
Enantiomeric excess was determined by chiral HPLC analysis (Chiralcel OD-H, 1.0 mL/min, 
95:05 hexanes/iPrOH): tR(major) = 26.79 min, tR(minor) = 24.80 min. [α]25D= +1.6° (c = 0.390 
CHCl3). 1H NMR (500 MHz, CDCl3) δ 7.15 (d, J = 8.7 Hz, 2H), 6.83 (d, J = 8.7 Hz, 2H), 3.82 
(s, 3H), 3.77 (s, 3H), 3.73 - 3.67 (m, 1H), 3.60 (s, 3H), 3.26 (dd, J = 17.7, 7.4 Hz, 1H), 3.20 (dd, 
J = 17.7, 6.8 Hz, 1H), 2.69 (dd, J = 15.6, 7.5 Hz, 1H), 2.63 (dd, J = 15.6, 7.4 Hz, 1H). 13C NMR 
(126 MHz, CDCl3) δ 192.12, 172.04, 161.03, 158.49, 134.32, 128.26, 114.04, 55.20, 52.98, 
51.67, 45.27, 40.54, 36.00. HRMS (ESI) Calcd for [M+H]+ 295.1176, Found 295.1187. 
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Dimethyl 2-oxo-4-(4-(trifluoromethyl)phenyl)hexanedioate (15i): 91% yield, 96% ee. 
Enantiomeric excess was determined by chiral HPLC analysis (Regis Pirkle Covalent (S,S) 
Whelk-O1 FEL, 1.0 mL/min, 90:10 hexanes/iPrOH): tR(major) = 21.29 min, tR(minor) = 18.36 
min. [α]25D= +4. 9° (c = 0.300 CHCl3). 1H NMR (500 MHz, CDCl3) δ 7.56 (d, J = 7.5 Hz, 2H), 
7.37 (d, J = 7.7 Hz, 2H), 3.86 - 3.78 (m, J = 14.0 Hz, 4H), 3.61 (s, 3H), 3.36 - 3.23 (m, 2H), 2.78 
- 2.63 (m, J = 7.8 Hz, 2H). 13C NMR (126 MHz, CDCl3) δ 191.46, 171.54, 160.84, 146.39, 
129.52, 129.26, 127.78, 125.73, 125.70, 125.67, 125.63, 125.10, 122.93, 53.11, 51.81, 44.74, 
39.86, 36.37. HRMS (ESI) Calcd for [M+H]+ 333.0944, Found 333.0956. 
 
Dimethyl 4-(4-nitrophenyl)-2-oxohexanedioate (15j): 95% yield, 95% ee. Enantiomeric 
excess was determined by chiral HPLC analysis (Chiralcel AD-H, 1.0 mL/min, 90:10 
hexanes/iPrOH): tR(major) = 37.43 min, tR(minor) = 40.73 min. [α]25D= +11.9° (c = 0.285 
CHCl3). 1H NMR (500 MHz, CDCl3) δ 8.18 (d, J = 8.6 Hz, 2H), 7.44 (d, J = 8.7 Hz, 2H), 3.91 - 
3.81 (m, 4H), 3.62 (s, 3H), 3.38 - 3.25 (m, 2H), 2.77 (dd, J = 16.1, 7.1 Hz, 1H), 2.69 (dd, J = 
16.1, 7.8 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 191.16, 171.26, 160.75, 149.84, 147.02, 
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128.41, 123.97, 53.21, 51.92, 44.55, 39.66, 36.32. HRMS (ESI) Calcd for [M+H]+ 310.0921, 
Found 310.1002. 
 
Dimethyl 4-(4-cynaophenyl)-2-oxohexanedioate (15k): 95% yield, 99% ee. Enantiomeric 
excess was determined by chiral HPLC analysis (Chiralcel AD-H, 1.0 mL/min, 90:10 
hexanes/iPrOH): tR(major) = 34.03 min, tR(minor) = 35.85 min. [α]25D= +7.0° (c = 0.405 CHCl3). 
1H NMR (500 MHz, CDCl3) δ 7.60 (d, J = 8.1 Hz, 2H), 7.37 (d, J = 8.1 Hz, 2H), 3.84 (s, 3H), 
3.82 - 3.76 (m, 1H), 3.60 (s, 3H), 3.34 - 3.22 (m, 2H), 2.73 (dd, J = 16.0, 7.1 Hz, 1H), 2.66 (dd, J 
= 16.0, 7.7 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 191.24, 171.33, 160.76, 147.80, 132.53, 
128.31, 118.59, 111.09, 53.18, 51.88, 44.52, 39.63, 36.53. HRMS (ESI) Calcd for [M+H]+ 
290.1023, Found 290.1097. 
 
Dimethyl 4-(4-formylphenyl)-2-oxohexanedioate (15l): 97% yield, 98% ee. Enantiomeric 
excess was determined by chiral HPLC analysis (Chiralcel AD-H, 1.0 mL/min, 90:10 
hexanes/iPrOH): tR(major) = 33.80 min, tR(minor) = 37.24 min. [α]25D= +7.2° (c = 0.400 CHCl3). 
1H NMR (500 MHz, CDCl3) δ 9.97 (s, 1H), 7.82 (d, J = 8.1 Hz, 2H), 7.42 (d, J = 8.1 Hz, 2H), 
3.90 - 3.78 (m, 4H), 3.60 (s, 3H), 3.37 - 3.23 (m, 2H), 2.75 (dd, J = 15.9, 7.3 Hz, 1H), 2.69 (dd, J 
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= 15.9, 7.6 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 191.71, 191.41, 171.50, 160.82, 149.37, 
135.38, 130.18, 128.11, 53.13, 51.83, 44.64, 39.78, 36.67. HRMS (ESI) Calcd for [M+H]+ 
293.1020, Found 293.1064. 
 
Dimethyl 4-(3-chlorophenyl)-2-oxohexanedioate (15m): 93% yield, 98% ee. Enantiomeric 
excess was determined by chiral HPLC analysis (Chiralcel OD-H, 1.0 mL/min, 90:10 
hexanes/iPrOH): tR(major) = 17.27 min, tR(minor) = 19.16 min. [α]25D= +11.0° (c = 0.550 
CHCl3). 1H NMR (500 MHz, CDCl3) δ 7.28 - 7.18 (m, 3H), 7.13 (d, J = 7.3 Hz, 1H), 3.84 (s, 
3H), 3.72 (p, J = 7.2 Hz, 1H), 3.61 (s, 3H), 3.28 (dd, J = 17.2, 6.3 Hz, 1H), 3.23 (dd, J = 17.2, 
5.8 Hz, 1H), 2.67 (qd, J = 15.9, 7.4 Hz, 2H). 13C NMR (63 MHz, CDCl3) δ 191.59, 171.66, 
160.91, 144.47, 134.50, 130.02, 127.50, 127.36, 125.67, 100.01, 53.10, 51.81, 44.87, 40.03, 
36.34. HRMS (ESI) Calcd for [M+H]+ 299.0681, Found 299.0695. 
 
Dimethyl 4-(3-bromophenyl)-2-oxohexanedioate (15n): 92% yield, 99% ee. Enantiomeric 
excess was determined by chiral HPLC analysis (Chiralcel OD-H, 0.7 mL/min, 97:03 
hexanes/iPrOH): tR(major) = 50.89 min, tR(minor) = 54.37 min. [α]25D= +4.3° (c = 0.445 CHCl3). 
1H NMR (500 MHz, CDCl3) δ 7.38 (s, 1H), 7.37 - 7.33 (m, 1H), 7.21 - 7.14 (m, 2H), 3.84 (s, 
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3H), 3.75 - 3.67 (m, 1H), 3.61 (s, 3H), 3.25 (dd, J = 7.0, 4.2 Hz, 2H), 2.70 (dd, J = 15.9, 7.5 Hz, 
1H), 2.64 (dd, J = 15.9, 7.3 Hz, 1H). 13C NMR (63 MHz, CDCl3) δ 191.57, 171.65, 160.91, 
149.40, 144.76, 130.41, 130.31, 126.15, 122.74, 53.12, 51.82, 44.87, 40.04, 36.32. HRMS (ESI) 
Calcd for [M+H]+ 343.0176, Found 343.0114. 
 
(E)-Dimethyl 2-oxo-4-styrylhexanedioate (15o): 93% yield, 94% ee. Enantiomeric excess 
was determined by chiral HPLC analysis (Chiralcel OD-H, 1.0 mL/min, 90:10 hexanes/iPrOH): 
tR(major) = 17.12 min, tR(minor) = 15.00 min. [α]25D= -19.7° (c = 0.285 CHCl3). 1H NMR (500 
MHz, CDCl3) δ 7.36 - 7.26 (m, J = 11.5, 7.7 Hz, 4H), 7.23 (d, J = 7.1 Hz, 1H), 6.48 (d, J = 15.9 
Hz, 1H), 6.11 (dd, J = 15.9, 8.3 Hz, 1H), 3.84 (s, 3H), 3.67 (s, 3H), 3.37 - 3.28 (m, 1H), 3.14 (dd, 
J = 17.6, 7.2 Hz, 1H), 3.06 (dd, J = 17.6, 6.2 Hz, 1H), 2.55 (d, J = 7.0 Hz, 2H). 13C NMR (126 
MHz, CDCl3) δ 192.26, 171.99, 161.15, 136.67, 131.36, 130.11, 128.51, 127.57, 126.28, 53.04, 
51.72, 43.62, 38.86, 34.61. HRMS (ESI) Calcd for [M+H]+ 291.1227, Found 291.1294. 
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1H NMR of Compound 15d 
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1H NMR of Compound 15g 
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1H NMR of Compound 15i 
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1H NMR of Compound 15j 
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1H NMR of Compound 15l 
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1H NMR of Compound 15m 
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1H NMR of Compound 15o 
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